Deals Library
655 deals · 99 sectors · sorted by entry_year desc
🛡️ Public data only — no PHI permitted on this instance.
About this page
Browsable 655-deal healthcare-PE corpus — name, sponsor, entry year, sector, EV / EBITDA multiple, realized MOIC and IRR, hold period, commercial-payer %, vintage regime, and data grade per row.
Scale
Data grade A–D reflects row completeness: A = all core fields populated (entry + exit + payer mix + returns); D = thin, sponsor or returns missing. Sort by any column.
How to use
Filter by sector + regime to assemble comparables for a target; click a deal row to open its detail view.
Source: data_public/deal_quality_score.py (grading) + data_public/deals_corpus._SEED_DEALS + extended_seed_*.py.
Total Deals
655
in corpus
Realized
365
56% of corpus
Corpus P50 MOIC
2.80x
realized deals
Loss Rate
14.8%
MOIC < 1.0×
Sectors
98
covered
DEAL CORPUSall healthcare PE transactions655
| Deal | Sector | Year | Regime | EV ($M) | EV/EBITDA | MOIC | IRR | Hold (yr) | Lev% | Comm% | Sponsor | Region | Grade |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Steward Health Care – MPT / Chapter 11 Restructuring | — | 2,024 | NORMALIZATION | $1B | — | — | — | — | — | — | Various (distressed acquirers) | — | D |
| Envision Healthcare Post-Reorg – New KKR Entity (2024) | — | 2,024 | NORMALIZATION | $2B | 6.2x | — | — | — | — | — | KKR (post-reorganization equit | — | C |
| BrightSpring Health Services – KKR IPO | — | 2,024 | NORMALIZATION | $5B | 15.0x | 2.10x | 16.0% | 5.0 | — | — | Public markets (NASDAQ: BTSG) | — | B |
| Steward Health Care – Texas Hospital Portfolio Sale | — | 2,024 | NORMALIZATION | $400M | — | — | — | — | — | 22% | Various (Stewardship Health / | — | D |
| ResCare / BrightSpring Health Services – KKR IPO | — | 2,024 | NORMALIZATION | $3B | 10.8x | 1.40x | 6.0% | 6.0 | — | 15% | Public Market (IPO) | — | B |
| Ardent Health Services IPO — 2024 | hospital | 2,024 | NORMALIZATION | $4B | 11.6x | — | — | — | — | 32% | IPO / Equity Group Investments | — | B |
| Concentra / Humana Divestiture | Occupational Health | 2,024 | NORMALIZATION | $2B | 10.0x | — | — | — | 55% | 80% | Welsh Carson / Concentra manag | National | A |
| Nuvance Health – Northwell Health Merger | — | 2,023 | NORMALIZATION | $4B | 13.3x | — | — | — | — | 40% | Northwell Health | — | C |
| Ramsay Health Care – US Market Entry via Covenant Health JV | — | 2,023 | NORMALIZATION | $4B | 13.5x | — | — | — | — | 33% | Ramsay Health Care / KKR (co-i | — | C |
| Radiology Partners – New Mountain Capital Recapitalization | — | 2,023 | NORMALIZATION | $3B | 8.4x | — | — | — | — | — | New Mountain Capital (recap / | — | C |
| Amedisys – UnitedHealth/Optum Acquisition | — | 2,023 | NORMALIZATION | $3B | 15.7x | — | — | — | — | — | UnitedHealth Group / Optum | — | C |
| LHC Group – Optum (completed) | — | 2,023 | NORMALIZATION | $5B | 14.6x | — | — | — | — | — | UnitedHealth Group / Optum | — | C |
| R1 RCM – New Mountain Capital / TCP-ASC Take-Private | — | 2,023 | NORMALIZATION | $9B | 15.1x | — | — | — | — | — | New Mountain Capital / TCP-ASC | — | C |
| Prospect Medical Holdings – Distressed Asset Sales | — | 2,023 | NORMALIZATION | $600M | — | — | — | — | — | — | State of CT / Various acquirer | — | D |
| Oak Street Health – CVS Health Acquisition | — | 2,023 | NORMALIZATION | $11B | 124.7x | — | — | — | — | — | CVS Health | — | D |
| Signify Health – CVS Health Acquisition | — | 2,023 | NORMALIZATION | $8B | 34.8x | — | — | — | — | — | CVS Health | — | C |
| SCA Health (Surgical Care Affiliates) – Bain Capital Roll-Up | — | 2,023 | NORMALIZATION | $900M | 10.6x | — | — | — | — | — | Bain Capital (through SCA Heal | — | C |
| Dermatology-Adjacent: Solta Medical – Bausch Health Carve-Out | — | 2,023 | NORMALIZATION | $3B | 14.4x | — | — | — | — | — | Public markets (Bausch + Lomb | — | C |
| Envision Healthcare – Post-Reorganization Creditor Entity 2023 | — | 2,023 | NORMALIZATION | $1B | 12.6x | — | — | — | — | 50% | New Envision creditor consorti | — | C |
| Prospect Medical Holdings – CA Hospitals Distressed Sale | — | 2,023 | NORMALIZATION | $150M | — | 0.10x | -25.0% | 8.0 | — | 15% | KPC Medical Management | — | B |
| National Oncology Ventures – US Oncology / McKesson Add-on | — | 2,023 | NORMALIZATION | $1B | 11.2x | — | — | — | — | 37% | US Oncology / McKesson | — | C |
| Alignment Healthcare – TPG Secondary Block Sale | — | 2,023 | NORMALIZATION | $900M | — | 0.60x | -9.0% | 5.0 | — | 5% | Block purchasers | — | C |
| Steward Medical Group – Optum Physician Group Acquisition | — | 2,023 | NORMALIZATION | $310M | — | — | — | — | — | 28% | Optum | — | D |
| Evolent Health – National Imaging Associates Acquisition | — | 2,023 | NORMALIZATION | $975M | 14.3x | — | — | — | — | — | Evolent Health | — | C |
| Amedisys – UnitedHealth Group / Optum Acquisition | — | 2,023 | NORMALIZATION | $3B | 19.6x | — | — | — | — | 10% | UnitedHealth Group / Optum | — | C |
| Signify Health – CVS Health / Aetna Acquisition | — | 2,023 | NORMALIZATION | $8B | 44.4x | 4.50x | 46.0% | 4.0 | — | 7% | New Mountain Capital | — | B |
| One Medical (1Life Healthcare) – Amazon Acquisition | — | 2,023 | NORMALIZATION | $4B | — | 1.50x | 15.0% | 3.0 | — | 85% | Amazon | — | B |
| MedExpress (Optum) / Urgent Care Divest | — | 2,023 | NORMALIZATION | $700M | 12.7x | — | — | 3.0 | — | 65% | Warren Equity Partners | National | B |
| Myriad Genetics / Oncology Segment | — | 2,023 | NORMALIZATION | $600M | 13.3x | — | — | 3.0 | — | 50% | Tempus AI (majority stake) | National | B |
| Cardiovascular Systems (CSII) / Abbott Acquisition | — | 2,023 | NORMALIZATION | $890M | 14.8x | — | — | — | — | 38% | Abbott Laboratories | Midwest | B |
| Parsley Health / Deutsche Telekom (T-Health) | — | 2,023 | NORMALIZATION | $200M | — | 1.80x | 22.0% | 3.0 | — | 55% | Deutsche Telekom (T-Systems) | National | C |
| Globus Medical / NuVasive Merger | — | 2,023 | NORMALIZATION | $3B | 13.5x | — | — | — | — | 45% | Globus Medical | National | B |
| Envision Anesthesia / USAP | — | 2,023 | NORMALIZATION | $1B | 12.6x | — | — | 4.0 | — | 44% | US Anesthesia Partners | National | B |
| Envision Healthcare / KKR bankruptcy exit | emergency_medicine | 2,023 | NORMALIZATION | $1B | — | 0.10x | -30.0% | 6.0 | — | 38% | KKR (exit via restructuring) | — | B |
| Amedisys / Optum (UHG) acquisition | home_health | 2,023 | NORMALIZATION | $3B | 15.0x | — | — | — | — | 10% | UnitedHealth Group / Optum | — | B |
| Nuvance Health / Northwell Health affiliation | hospital | 2,023 | NORMALIZATION | $2B | 9.0x | — | — | — | — | 32% | Northwell Health (nonprofit st | — | B |
| United Surgical Partners International — Optum Majority Acquisition | asc | 2,023 | NORMALIZATION | $6B | 11.3x | — | — | — | — | 46% | UnitedHealth Group / Optum | — | B |
| Mochi Health — 8VC / Peterson | managed_care | 2,023 | NORMALIZATION | $150M | — | — | — | — | — | 40% | 8VC / Peterson Ventures | — | D |
| Fortrea (LabCorp CRO spinoff) / THL | Clinical Research / CRO | 2,023 | NORMALIZATION | $4B | 10.0x | — | — | — | 45% | 90% | Thomas H. Lee Partners (minori | Global | A |
| Athletico Physical Therapy / BDT & MSD | Physical Therapy | 2,023 | NORMALIZATION | $3B | 13.3x | — | — | — | 58% | 65% | BDT & MSD Partners | Midwest | A |
| CareDx – Medline / Growth Buyout | Transplant / Diagnostics | 2,023 | NORMALIZATION | $520M | 14.9x | — | — | — | 42% | 70% | Blackstone Growth | National | B |
| SaVida Health – Behavioral Health Partners (SUD focus) | — | 2,022 | PEAK | $90M | 9.0x | — | — | — | — | 38% | SaVida Health / Revelstoke Cap | — | C |
| Lifepoint Health — Post-Merger Debt Refinancing (KKR hold-period) | — | 2,022 | PEAK | $10B | 11.2x | — | — | — | — | 29% | LifePoint Health (existing KKR | — | C |
| Covenant Physician Partners – KKR (Platform Build) | — | 2,022 | PEAK | $2B | 10.0x | — | — | — | — | — | KKR | — | C |
| Resilient Healthcare – Halo Capital Group / CrossFirst Bank | — | 2,022 | PEAK | $75M | 7.5x | — | — | — | — | — | Halo Capital Group | — | C |
| US Physical Therapy – ATI Physical Therapy add-on targets | — | 2,022 | PEAK | $180M | 10.0x | — | — | — | — | — | ATI Physical Therapy (Advent b | — | C |
| Surgery Partners – Multiple ASC Platform Add-Ons (2022) | — | 2,022 | PEAK | $650M | 10.0x | — | — | — | — | — | Surgery Partners (SGRY / Bain | — | C |
| Change Healthcare – UnitedHealth/Optum Acquisition | — | 2,022 | PEAK | $13B | 14.4x | — | — | — | — | — | UnitedHealth Group / Optum | — | C |
| National Healthcare Corp – SNF Portfolio Consolidation | — | 2,022 | PEAK | $320M | 9.1x | — | — | — | — | — | NHC (public, internally consol | — | C |
| Radiology Partners – New Mountain Capital (2022 refinance) | — | 2,022 | PEAK | $4B | 13.1x | — | — | — | — | — | New Mountain Capital (existing | — | C |
| Apria Healthcare – Owens & Minor Acquisition | — | 2,022 | PEAK | $2B | 11.2x | — | — | — | — | — | Owens & Minor (OMI) | — | C |
| USPI / Tenet Healthcare – ASC Add-on Cluster 2022 | — | 2,022 | PEAK | $1B | 7.7x | — | — | — | — | 73% | United Surgical Partners Inter | — | C |
| Ensemble Health Partners – Golden Gate Capital Minority Recap | — | 2,022 | PEAK | $4B | 12.5x | — | — | — | — | — | Golden Gate Capital | — | C |
| Spring Health – General Catalyst Series D Growth Round | — | 2,022 | PEAK | $2B | — | — | — | — | — | 93% | General Catalyst | — | D |
| Ovation Healthcare – Delphi Private Equity LBO | — | 2,022 | PEAK | $520M | 10.0x | — | — | — | — | 22% | Delphi Private Equity | — | C |
| R1 RCM – Cloudmed Acquisition | — | 2,022 | PEAK | $4B | 14.1x | — | — | — | — | — | R1 RCM | — | C |
| Carbon Health – Blackstone Growth Equity | — | 2,022 | PEAK | $3B | — | — | — | — | — | 68% | Blackstone Growth | — | D |
| EviCore Healthcare – Restructured AIM Specialty Health | — | 2,022 | PEAK | $2B | 11.2x | — | — | — | — | — | Cigna / eviCore | — | C |
| NephroStar – Dialysis Clinic Roll-up | — | 2,022 | PEAK | $450M | 11.2x | — | — | — | — | 12% | Warburg Pincus | — | C |
| Apria Healthcare – Owens & Minor Acquisition | — | 2,022 | PEAK | $2B | 8.9x | — | — | — | — | 23% | Owens & Minor | — | C |
| Gentiva Health Services – Clayton Dubilier & Rice LBO | — | 2,022 | PEAK | $4B | 13.6x | — | — | — | — | 8% | Clayton Dubilier & Rice | — | C |
| Change Healthcare – UnitedHealth Group / Optum Acquisition | — | 2,022 | PEAK | $13B | 19.1x | — | — | 1.0 | — | — | UnitedHealth Group / Optum | — | C |
| SCA Health – Bain Capital Secondary LBO | — | 2,022 | PEAK | $4B | 11.5x | — | — | — | — | 76% | Bain Capital | — | C |
| Lifepoint Health – Kindred Rehab Add-on Portfolio | — | 2,022 | PEAK | $700M | 11.3x | — | — | — | — | 18% | LifePoint Health / Apollo | — | C |
| Astrana Health – VBC Platform Expansion 2022 | — | 2,022 | PEAK | $830M | 11.9x | — | — | — | — | 20% | Astrana Health (public) | — | C |
| Enhabit Home Health & Hospice – Encompass Health Spin-off | — | 2,022 | PEAK | $2B | 15.0x | — | — | — | — | 13% | Public Market (spin-off) | — | C |
| Surgical Notes – ASC Revenue Cycle SaaS Platform | — | 2,022 | PEAK | $290M | 10.4x | — | — | — | — | — | GTCR | — | C |
| Diversicare Healthcare – PE Recapitalization | — | 2,022 | PEAK | $320M | 9.1x | — | — | — | — | 12% | Diversicare management / LP in | — | C |
| Hazel Health – School-Based Health Platform Growth | — | 2,022 | PEAK | $500M | — | — | — | — | — | 35% | Owl Ventures | — | D |
| WRS Health / Bizmatics – Ambulatory EHR Roll-up | — | 2,022 | PEAK | $380M | 10.0x | — | — | — | — | — | Thoma Bravo | — | C |
| Maven Clinic – Women's Health Platform Series E | — | 2,022 | PEAK | $1B | — | — | — | — | — | 88% | General Atlantic | — | D |
| Nuance Communications – Microsoft Acquisition | — | 2,022 | PEAK | $20B | 63.5x | — | — | — | — | — | Microsoft | — | D |
| Cotiviti – Veritas Capital Secondary LBO | — | 2,022 | PEAK | $15B | 13.6x | — | — | — | — | — | Veritas Capital | — | C |
| Carrum Health – Episode-Based Surgery Platform | — | 2,022 | PEAK | $220M | — | — | — | — | — | 90% | Health Assurance Acquisition / | — | D |
| Pearl Health – Primary Care ACO-REACH Platform | — | 2,022 | PEAK | $380M | — | — | — | — | — | 2% | a16z / General Catalyst | — | D |
| Acadia Healthcare / Lindner Center Add-On | — | 2,022 | PEAK | $175M | 9.7x | — | — | 3.0 | — | 40% | Acadia Healthcare | Midwest | B |
| Retina Consultants of America / KKR | — | 2,022 | PEAK | $2B | 13.8x | — | — | 4.0 | — | 35% | KKR | National | B |
| Upstream Rehabilitation / Revelstoke Capital | — | 2,022 | PEAK | $2B | 12.9x | — | — | 4.0 | — | 40% | Revelstoke Capital Partners | National | B |
| Magellan Health / Centene Acquisition | — | 2,022 | PEAK | $2B | 12.6x | — | — | — | — | 25% | Centene Corporation | National | B |
| AMN Healthcare / Connetics / Travel Nursing Roll-up | — | 2,022 | PEAK | $1B | 12.7x | — | — | — | — | — | AMN Healthcare Services | National | C |
| Inovalon / Nordic Capital Take-Private | — | 2,022 | PEAK | $7B | 19.2x | — | — | 5.0 | — | — | Nordic Capital | National | C |
| Diversicare Healthcare / Wellstone Capital | — | 2,022 | PEAK | $280M | 12.7x | — | — | 4.0 | — | 8% | Wellstone Capital | Southeast | B |
| Maternal Fetal Medicine of America / Kainos Capital | — | 2,022 | PEAK | $280M | 10.8x | — | — | 5.0 | — | 55% | Kainos Capital | Southeast | B |
| Kyruus Health / Vista Equity | — | 2,022 | PEAK | $600M | 12.0x | — | — | 5.0 | — | — | Vista Equity Partners | National | C |
| Invitae / GeneDx Merger | — | 2,022 | PEAK | $150M | — | 0.10x | -70.0% | 2.0 | — | 58% | Invitae | National | C |
| Calibrate Health / AXA Venture Partners | — | 2,022 | PEAK | $200M | — | 0.40x | -24.0% | 3.0 | — | 60% | AXA Venture Partners | National | C |
| YesCare (formerly Corizon Health) / Restructuring | — | 2,022 | PEAK | $200M | 11.1x | — | — | 3.0 | — | 0% | Management buyout / restructur | National | B |
| Pomelo Care / Oak HC/FT | — | 2,022 | PEAK | $200M | — | — | — | 4.0 | — | 44% | Oak HC/FT | National | D |
| SCAN Health Plan / CareOregon merger (SCAN Group) | managed_care | 2,022 | PEAK | $600M | — | — | — | — | — | 0% | SCAN Group strategic | — | D |
| Inovalon / Nordic Capital + Insight Partners take-private | health_it | 2,022 | PEAK | $7B | 54.9x | — | — | — | — | — | Nordic Capital / Insight Partn | — | D |
| American Renal Associates — Centerbridge Take-Private | dialysis | 2,022 | PEAK | $775M | 10.3x | 2.00x | 26.0% | 3.0 | — | 24% | Centerbridge Partners | — | A |
| TeamHealth — Blackstone Exit via Sponsor Secondary | physician_group | 2,022 | PEAK | $6B | 13.1x | 1.20x | 3.0% | 7.0 | — | 47% | Blackstone (continued hold) | — | A |
| Nomi Health — Blackstone Growth Equity | health_it | 2,022 | PEAK | $750M | 15.0x | — | — | — | — | 65% | Blackstone Growth | — | B |
| Meditrina — General Catalyst VC Backed | health_it | 2,022 | PEAK | $250M | — | — | — | — | — | 65% | General Catalyst | — | D |
| Thyme Care — Andreessen Horowitz Growth | oncology | 2,022 | PEAK | $350M | — | — | — | — | — | 38% | a16z / General Catalyst | — | D |
| MedBridge — Summit Partners Buyout | health_it | 2,022 | PEAK | $350M | 9.2x | — | — | — | — | 50% | Summit Partners | — | B |
| Amazon One Medical — Amazon Acquisition | managed_care | 2,022 | PEAK | $4B | 65.0x | — | — | — | — | 62% | Amazon | — | C |
| Zing Health — General Catalyst / HCSC | managed_care | 2,022 | PEAK | $500M | — | — | — | — | — | 2% | General Catalyst / Health Care | — | D |
| Interwell Health / Cricket Health Merger — KKR | dialysis | 2,022 | PEAK | $1B | 25.0x | — | — | — | — | 18% | KKR | — | B |
| CVS Health / Signify Health — Strategic Acquisition | managed_care | 2,022 | PEAK | $8B | 25.0x | — | — | — | — | 13% | CVS Health | — | B |
| Nuvation Bio — ARCH Venture / RTW Investments | oncology | 2,022 | PEAK | $3B | — | — | — | — | — | 29% | RTW Investments / ARCH | — | D |
| NorthStar Anesthesia / KKR | Anesthesiology | 2,022 | PEAK | $2B | 12.6x | — | — | — | 62% | 55% | KKR | National | A |
| AlerisLife / ABP Acquisition | Senior Living | 2,022 | PEAK | $100M | 12.5x | 0.80x | — | 1.0 | 40% | 5% | ABP Acquisition LLC (Portnoy g | National | A |
| Ensemble Health Partners / CD&R | Revenue Cycle Management | 2,022 | PEAK | $4B | 11.8x | — | — | — | 60% | 55% | Clayton, Dubilier & Rice | National | A |
| Paladin / Endo device spinoff | Medical Devices | 2,022 | PEAK | $3B | 8.0x | — | — | — | 50% | 60% | CPPIB / management | National | A |
| Marathon Health / Morgan Health (JPMorgan) | Employer Health | 2,022 | PEAK | $700M | 15.6x | — | — | — | 25% | 100% | Morgan Health (JPMorgan strate | National | A |
| Tivity Health / Prime – Marlin Equity | Wellness / Fitness Health | 2,022 | PEAK | $160M | 8.9x | — | — | — | 58% | 42% | Marlin Equity Partners | National | B |
| CAPA Health – GI Alliance Add-On | Gastroenterology | 2,022 | PEAK | $95M | 8.6x | — | — | — | 50% | 62% | Ares Management | West | B |
| OrthoSouth – Alaris Capital Partners | Orthopedics | 2,022 | PEAK | $180M | 10.0x | 2.80x | 38.0% | 3.0 | — | 68% | Alaris Capital Partners | South | A |
| ScionHealth – Kindred LTAC Spinoff | — | 2,021 | PEAK | $2B | 11.6x | — | — | — | — | 20% | TPG Capital / Welsh Carson | — | C |
| Kindred at Home – Humana Full Acquisition | — | 2,021 | PEAK | $8B | 18.0x | — | — | — | — | 18% | Humana | — | C |
| Behavioral Health Group – Revelstoke Capital | — | 2,021 | PEAK | $250M | 7.8x | — | — | — | — | — | Revelstoke Capital | — | C |
| ScionHealth – LTAC Spinoff from LifePoint/KKR | — | 2,021 | PEAK | $1B | 8.1x | — | — | — | — | — | KKR (Scion portfolio company) | — | C |
| VillageMD – Walgreens Boots Alliance Strategic Investment | — | 2,021 | PEAK | $5B | 57.8x | — | — | — | — | — | Walgreens Boots Alliance | — | D |
| Agilon Health – Advent International / IPO | — | 2,021 | PEAK | $6B | — | 4.20x | 38.0% | 5.0 | — | — | Public (IPO — NYSE: AGL) | — | C |
| Gentiva Health (Kindred at Home) – Humana / Clayton Dubilier | — | 2,021 | PEAK | $3B | 12.2x | — | — | — | — | — | Clayton Dubilier & Rice / Huma | — | C |
| Behavioral Health Group (BHG) – GTCR Platform | — | 2,021 | PEAK | $450M | 10.0x | — | — | — | — | — | GTCR | — | C |
| National Spine & Pain Centers – Avista Capital Partners | — | 2,021 | PEAK | $380M | 9.5x | — | — | — | — | — | Avista Capital Partners | — | C |
| Ardent Health Services – Equity Capital (2021 refinancing) | — | 2,021 | PEAK | $3B | 12.4x | — | — | — | — | — | Equity Group Investments / Ven | — | C |
| Covenant Physician Partners – USPI / Tenet acquisition | — | 2,021 | PEAK | $1B | 11.7x | 4.50x | 27.0% | 6.0 | — | — | United Surgical Partners Inter | — | B |
| American Renal Associates – Acacia Research / Nuvei | — | 2,021 | PEAK | $865M | 7.9x | — | — | — | — | — | Acacia Research / Nuvei Group | — | C |
| Alignment Healthcare – IPO / Warburg Pincus exit | — | 2,021 | PEAK | $4B | — | 3.80x | 30.0% | 5.0 | — | — | Public markets (NASDAQ: ALHC) | — | B |
| CareMax – IMC Medical Group SPAC Merger | — | 2,021 | PEAK | $2B | 60.0x | — | — | — | — | — | CareMax / Deerfield Management | — | D |
| LabCorp – Ascension Health Labs Acquisition | — | 2,021 | PEAK | $400M | 8.9x | — | — | — | — | — | Labcorp (Laboratory Corporatio | — | C |
| ChenMed – Underhill Investment Partners Minority Recapitalization | — | 2,021 | PEAK | $4B | 16.7x | — | — | — | — | — | Underhill Investment Partners | — | C |
| Pediatric Associates – KKR Platform Build | — | 2,021 | PEAK | $2B | 12.0x | — | — | — | — | — | KKR | — | C |
| ModivCare – Matrix Medical Network + Simplura Health Acquisitions | — | 2,021 | PEAK | $1B | 11.7x | — | — | — | — | — | ModivCare (formerly Providence | — | C |
| Acadia Healthcare – Behavioral Portfolio Add-ons 2021 | — | 2,021 | PEAK | $680M | 9.4x | 2.10x | 19.0% | 4.0 | — | 24% | Acadia Healthcare | — | B |
| Privia Health Group – IPO / Goldman Sachs / Blackstone Exit | — | 2,021 | PEAK | $3B | 114.3x | 1.80x | 22.0% | 4.5 | — | 46% | Public Market (IPO) | — | C |
| Agilon Health – IPO / Clayton Dubilier & Rice Exit | — | 2,021 | PEAK | $6B | — | 0.70x | -14.0% | 3.0 | — | 3% | Public Market (IPO) | — | B |
| Kindred at Home – LHC Group Acquisition (Humana Stake) | — | 2,021 | PEAK | $3B | 13.3x | — | — | — | — | 15% | LHC Group | — | C |
| Cano Health – SPAC / Jaws Acquisition Corp | — | 2,021 | PEAK | $4B | — | 0.05x | -70.0% | 2.5 | — | 8% | Jaws Acquisition Corp (SPAC) | — | B |
| LifeStance Health – IPO / TPG Capital Exit | — | 2,021 | PEAK | $7B | — | 0.45x | -28.0% | 3.0 | — | 80% | Public Market (IPO) | — | B |
| Netsmart Technologies – GI Partners LBO | — | 2,021 | PEAK | $2B | 13.4x | — | — | — | — | — | GI Partners | — | C |
| ScionHealth – LTACH Carve-out from LifePoint / Apollo | — | 2,021 | PEAK | $800M | 11.1x | — | — | — | — | 16% | ScionHealth (Apollo-backed) | — | C |
| US Dermatology Partners – ABRY Partners Recapitalization | — | 2,021 | PEAK | $1B | 11.1x | — | — | — | — | 68% | ABRY Partners | — | C |
| Integrated Medical Group – Virtus Investment Partner | — | 2,021 | PEAK | $250M | 8.9x | — | — | — | — | 48% | Virtus Medical Group Holdings | — | C |
| Concentra Group Holdings – Humana Exit / Select Medical IPO | — | 2,021 | PEAK | $4B | 14.5x | 2.40x | 16.0% | 6.0 | — | 80% | Public Market (IPO) / Humana | — | B |
| Labcorp – Ascension Health Laboratory Services Acquisition | — | 2,021 | PEAK | $400M | 10.0x | — | — | — | — | 35% | Labcorp | — | C |
| ProgenyHealth – Neonatal Care Management Platform | — | 2,021 | PEAK | $320M | 10.7x | — | — | — | — | 55% | General Atlantic | — | C |
| Gainwell Technologies – Veritas Capital / DXC Carve-out | — | 2,021 | PEAK | $5B | 13.2x | — | — | — | — | — | Veritas Capital | — | C |
| Absolute Care – UnitedHealth Group / Optum Acquisition | — | 2,021 | PEAK | $280M | 12.7x | 3.80x | 32.0% | 5.0 | — | 13% | UnitedHealth Group / Optum | — | B |
| Clearway Pain Solutions – Pain Management Platform | — | 2,021 | PEAK | $210M | 8.8x | — | — | — | — | 52% | Serent Capital | — | C |
| Shields Health Solutions – Walgreens Boots Alliance Majority Stake | — | 2,021 | PEAK | $2B | 15.2x | 3.20x | 28.0% | — | — | 40% | Walgreens Boots Alliance | — | B |
| Synchrony Health Services – Kindred + Genesis Post-Acute | — | 2,021 | PEAK | $280M | 11.7x | — | — | — | — | 10% | Synchrony Health management | — | C |
| ATI Physical Therapy – Advent International SPAC / Viant | — | 2,021 | PEAK | $3B | 26.8x | 0.30x | -38.0% | 2.0 | — | 72% | Public Market (SPAC) / Advent | — | B |
| Pathgroup – Genoptix / Sonic Healthcare Pathology Add-on | — | 2,021 | PEAK | $340M | 8.9x | — | — | — | — | 45% | Sonic Healthcare | — | C |
| National Spine & Pain Centers – Sentinel Capital Platform | — | 2,021 | PEAK | $480M | 9.6x | — | — | — | — | 55% | Sentinel Capital Partners | — | C |
| Landmark Health – UnitedHealth Group Acquisition | — | 2,021 | PEAK | $2B | 17.9x | 3.50x | 29.0% | 5.0 | — | 4% | UnitedHealth Group | — | B |
| Global Medical Response – KKR / Ardian Acquisition | — | 2,021 | PEAK | $6B | 11.2x | — | — | — | — | 30% | KKR / Ardian | — | C |
| Sound Physicians – TPG Capital Secondary Investment | — | 2,021 | PEAK | $2B | 13.9x | — | — | — | — | 44% | TPG Capital | — | C |
| Bright Health Group – IPO / New Enterprise Associates Exit | — | 2,021 | PEAK | $11B | — | 0.02x | -86.0% | 2.0 | — | 20% | Public Market (IPO) | — | B |
| Array Behavioral Care – Telepsychiatry Platform Growth | — | 2,021 | PEAK | $380M | 10.9x | — | — | — | — | 30% | Warburg Pincus | — | C |
| InfuSystem – GTCR Secondary Buyout | — | 2,021 | PEAK | $600M | 11.5x | — | — | — | — | 60% | GTCR | — | C |
| CenterWell Senior Primary Care – Humana Internal Build | — | 2,021 | PEAK | $2B | — | — | — | — | — | 5% | Humana (internal) | — | D |
| GI Alliance – Ares Management / HGGC Acquisition | — | 2,021 | PEAK | $3B | 12.7x | — | — | — | — | 63% | Ares Management / HGGC | — | C |
| VillageMD – Walgreens Boots Alliance Majority Stake | — | 2,021 | PEAK | $5B | — | 0.30x | -37.0% | 3.0 | — | 57% | Walgreens Boots Alliance | — | B |
| Tenet Healthcare – USPI Control Stake Acquisition | — | 2,021 | PEAK | $2B | 9.0x | 2.20x | 17.0% | 5.0 | — | 72% | Tenet Healthcare | — | B |
| Nexus Health Systems – Kelso & Company IRF Platform | — | 2,021 | PEAK | $540M | 9.8x | — | — | — | — | 20% | Kelso & Company | — | C |
| Landmark Health / UnitedHealth Group | — | 2,021 | PEAK | $4B | — | 7.00x | 48.0% | 5.0 | — | 8% | UnitedHealth Group / Optum | National | C |
| OrthoConnecticut / Martis Capital | — | 2,021 | PEAK | $320M | 11.4x | — | — | 4.0 | — | 50% | Martis Capital | Northeast | B |
| MedBridge / TA Associates | — | 2,021 | PEAK | $600M | 12.0x | — | — | 4.0 | — | — | TA Associates | National | C |
| BioReference Laboratories / OPKO Health Carve-Out | — | 2,021 | PEAK | $2B | 15.0x | — | — | 1.0 | — | 28% | Labcorp | Northeast | B |
| American Renal Associates / Nautic Partners | — | 2,021 | PEAK | $500M | 13.2x | — | — | 4.0 | — | 8% | Nautic Partners | National | B |
| Iora Health / One Medical Acquisition | — | 2,021 | PEAK | $1B | — | 9.00x | 55.0% | 5.0 | — | 18% | One Medical (1Life Healthcare) | National | C |
| Consulate Health Care / Restructuring | — | 2,021 | PEAK | $400M | 13.3x | 0.60x | -18.0% | 3.0 | — | 10% | CIFC / Restructured lenders | Southeast | B |
| Ciox Health / Datavant Merger | — | 2,021 | PEAK | $7B | 25.0x | 8.00x | 52.0% | 5.0 | — | — | Datavant | National | B |
| Brookdale Senior Living / Blackstone | — | 2,021 | PEAK | $3B | 15.0x | — | — | 4.0 | — | 12% | Blackstone Real Estate | National | B |
| Sevita (formerly RHA Health) / Charlesbank | — | 2,021 | PEAK | $3B | 14.0x | — | — | 4.0 | — | 5% | Charlesbank Capital Partners | National | B |
| Cardiovascular Associates of America / Bluewave Capital | — | 2,021 | PEAK | $420M | 11.1x | — | — | 5.0 | — | 30% | Bluewave Capital | Southeast | B |
| GI Alliance / Ares Management | — | 2,021 | PEAK | $2B | 12.9x | — | — | 5.0 | — | 45% | Ares Management | National | B |
| Doctor on Demand / Grand Rounds Merger | — | 2,021 | PEAK | $1B | — | 2.80x | 30.0% | 4.0 | — | 82% | Included Health (merged) | National | C |
| MEDNAX / Pediatrix Medical Group / Icahn | — | 2,021 | PEAK | $3B | 12.2x | — | — | 4.0 | — | 55% | Icahn Enterprises (activist st | National | B |
| Acadia Healthcare / Addiction Treatment Centers Add-Ons | — | 2,021 | PEAK | $350M | 10.9x | — | — | 3.0 | — | 40% | Acadia Healthcare | Southeast | B |
| Neurology Partners of America / Shore Capital | — | 2,021 | PEAK | $200M | 11.1x | — | — | 5.0 | — | 33% | Shore Capital Partners | Southeast | B |
| Clover Health / SPAC (Social Capital Hedosophia) | — | 2,021 | PEAK | $4B | — | 0.15x | -60.0% | 2.0 | — | 0% | Public via SPAC | National | C |
| Caron Treatment Centers / Riverside Company | — | 2,021 | PEAK | $260M | 10.8x | — | — | 5.0 | — | 65% | Riverside Company | Northeast | B |
| Casetabs / Insight Partners | — | 2,021 | PEAK | $180M | 12.0x | — | — | 4.0 | — | — | Insight Partners | National | C |
| Strive Health / General Catalyst | — | 2,021 | PEAK | $450M | — | — | — | 4.0 | — | 6% | General Catalyst | National | D |
| Medically Home / Oak HC/FT | — | 2,021 | PEAK | $400M | — | — | — | 4.0 | — | 28% | Oak HC/FT | National | D |
| Summa Health / Fairview Health Affiliation | — | 2,021 | PEAK | $2B | 13.6x | — | — | — | — | 28% | Summa Health (joint operating | Midwest | B |
| Aware Recovery Care / Warburg Pincus | — | 2,021 | PEAK | $300M | — | — | — | 4.0 | — | 48% | Warburg Pincus | Northeast | D |
| The Joint Corp / Franchise Roll-Up | — | 2,021 | PEAK | $400M | 12.5x | — | — | — | — | 40% | The Joint Corp (public franchi | National | B |
| Lyra Health / General Atlantic | — | 2,021 | PEAK | $5B | — | — | — | 4.0 | — | 85% | General Atlantic | National | D |
| Sabra Health Care REIT / Holiday Retirement | — | 2,021 | PEAK | $2B | 13.8x | — | — | — | — | 7% | Sabra Health Care REIT | National | B |
| American Oncology Network / GTCR | — | 2,021 | PEAK | $850M | 11.8x | — | — | 5.0 | — | 30% | GTCR | National | B |
| PPD (Pharmaceutical Product Development) / Thermo Fisher | — | 2,021 | PEAK | $17B | 12.9x | 5.50x | 28.0% | 7.0 | — | — | Thermo Fisher Scientific | National | B |
| IVX Health / Pharmos Capital | — | 2,021 | PEAK | $200M | 11.1x | — | — | 5.0 | — | 72% | Pharmos Capital | Southeast | B |
| RadNet / Imaging Center Acquisitions | — | 2,021 | PEAK | $2B | 10.9x | — | — | — | — | 43% | RadNet Inc. (Nasdaq: RDNT) | National | B |
| Color Genomics / PE Series D | — | 2,021 | PEAK | $470M | — | — | — | 4.0 | — | 55% | Various PE (Series D) | National | D |
| Aspirion Health RCM Distressed Debt-to-Equity | RCM / health IT | 2,021 | PEAK | $190M | 8.9x | 4.40x | 42.0% | 3.0 | — | — | Clearlake Capital Group | — | C |
| ATI Physical Therapy / Advent SPAC | physical_therapy | 2,021 | PEAK | $2B | 22.0x | — | — | — | — | 58% | Advent International via Fortr | — | B |
| LifeStance Health / TPG growth equity + IPO | behavioral_health | 2,021 | PEAK | $7B | — | 1.50x | 8.0% | 4.0 | — | 70% | TPG Capital / public IPO | — | B |
| Nomi Health / Deerfield Management growth equity | health_it | 2,021 | PEAK | $2B | — | — | — | — | — | — | Deerfield Management | — | D |
| Cano Health / InTandem Capital SPAC + Humana JV | primary_care | 2,021 | PEAK | $4B | — | 0.10x | -55.0% | 3.0 | — | 8% | InTandem Capital Partners via | — | B |
| American Renal Associates / Centerbridge take-private | dialysis | 2,021 | PEAK | $460M | 8.5x | 2.20x | 17.0% | 4.0 | — | 12% | Centerbridge Partners | — | A |
| BioTelemetry / Philips Healthcare acquisition | cardiology | 2,021 | PEAK | $3B | 28.0x | 5.50x | 38.0% | 4.0 | — | 28% | Philips Healthcare | — | B |
| Spring Health / General Catalyst growth equity | behavioral_health | 2,021 | PEAK | $2B | — | — | — | — | — | 70% | General Catalyst / Kinnevik | — | D |
| ModivCare / Providence Service add-on (personal care) | home_community_based | 2,021 | PEAK | $575M | 9.9x | 1.90x | 13.0% | 4.0 | — | 10% | Modivcare Inc. (public) | — | A |
| One Oncology / General Atlantic + US Oncology merger | oncology | 2,021 | PEAK | $2B | 16.0x | — | — | — | — | 34% | General Atlantic / US Oncology | — | B |
| Landmark Health — Optum Acquisition | managed_care | 2,021 | PEAK | $3B | 20.0x | 4.50x | 35.0% | 5.0 | — | 5% | Optum (UnitedHealth) | — | A |
| Strive Health — General Atlantic / WCAS | dialysis | 2,021 | PEAK | $700M | 23.3x | — | — | — | — | 18% | General Atlantic / WCAS | — | B |
| Covenant Physician Partners — Ares Management Buyout | asc | 2,021 | PEAK | $650M | 10.8x | 3.50x | 52.0% | 3.0 | — | 43% | Ares Management | — | A |
| RadNet — Significant Acquisition / Growth | radiology | 2,021 | PEAK | $2B | 12.0x | 2.80x | 39.0% | 3.0 | — | 38% | RadNet Management (Public, NAS | — | A |
| Imagine Health — Blackstone Growth Equity | managed_care | 2,021 | PEAK | $600M | 15.0x | — | — | — | — | 18% | Blackstone Growth | — | B |
| Iora Health — Humana Acquisition | managed_care | 2,021 | PEAK | $2B | 30.0x | 3.00x | 20.0% | 6.0 | — | 4% | One Medical (NASDAQ: ONEM) | — | A |
| US Dermatology Partners — BBAI / KKR Platform | physician_group | 2,021 | PEAK | $2B | 11.3x | 2.80x | 30.0% | 4.0 | — | 52% | KKR (secondary) | — | A |
| Northwell Health — Bond Issuance Benchmark | hospital | 2,021 | PEAK | $8B | 14.2x | — | — | — | — | 30% | Northwell Health (Bond Market) | — | B |
| Acrisure Health — Advent International | managed_care | 2,021 | PEAK | $1B | 10.9x | — | — | — | — | 75% | Advent International | — | B |
| Carbon Health — Dragoneer / OMERS Growth Equity | urgent_care | 2,021 | PEAK | $3B | — | — | — | — | — | 65% | Dragoneer Investment Group / O | — | D |
| Forward — SoftBank / Founders Fund | managed_care | 2,021 | PEAK | $800M | — | 0.00x | — | 2.0 | — | 85% | SoftBank Vision Fund 2 | — | C |
| Privia Health — Goldman Sachs / Vestar Capital IPO | physician_group | 2,021 | PEAK | $3B | 40.0x | 3.50x | 28.0% | 5.0 | — | 45% | IPO / Existing Investors | — | A |
| Nomi Health Direct Care — TPG / Goldman Growth | managed_care | 2,021 | PEAK | $1B | 16.7x | — | — | — | — | 70% | TPG / Goldman Sachs Growth | — | B |
| Walmart Health — Walmart (Strategic) Shutdown | managed_care | 2,021 | PEAK | $2B | — | 0.00x | — | 3.0 | — | 50% | Walmart (Internal Investment) | — | C |
| Spring Health — Teachers' VC / General Catalyst | behavioral_health | 2,021 | PEAK | $2B | — | — | — | — | — | 80% | Teachers' Venture Growth / Gen | — | D |
| Hims & Hers Health — Oaktree / Clients | health_it | 2,021 | PEAK | $2B | — | 1.50x | 15.0% | 3.0 | — | 25% | Public (NYSE: HIMS) via SPAC | — | B |
| Papa Inc — Comcast / Tiger Global | managed_care | 2,021 | PEAK | $1B | — | — | — | — | — | 5% | Comcast / Tiger Global | — | D |
| Cedar Gate Technologies — Warburg Pincus | health_it | 2,021 | PEAK | $600M | 10.9x | — | — | — | — | 45% | Warburg Pincus | — | B |
| Array Behavioral Care — General Catalyst / Summit | behavioral_health | 2,021 | PEAK | $500M | 11.9x | — | — | — | — | 35% | Summit Partners / General Cata | — | B |
| Smile Brands / Gryphon Investors | Dental | 2,021 | PEAK | $950M | 10.0x | — | — | — | 58% | 65% | Gryphon Investors | National | A |
| apree health / Welsh Carson | Employer Health | 2,021 | PEAK | $380M | 17.3x | — | — | — | 30% | 100% | Welsh Carson Anderson & Stowe | National | A |
| VillageMD / Walgreens Health | Primary Care | 2,021 | PEAK | $5B | 61.2x | 0.30x | — | 3.0 | 20% | 50% | Walgreens Boots Alliance (stra | National | A |
| ClearChoice Dental Implant Centers / Ares Management | Dental | 2,021 | PEAK | $2B | 12.0x | — | — | — | 60% | 25% | Ares Management | National | A |
| Acadia Healthcare Acquisition Program / Waud Capital | Behavioral Health | 2,021 | PEAK | $1B | 10.0x | — | — | — | 60% | 30% | Waud Capital Partners | National | A |
| Cano Health / SPAC / Chapter 11 | Primary Care | 2,021 | PEAK | $4B | 73.3x | 0.05x | — | 3.0 | 35% | 10% | InTandem Capital / SPAC | Southeast | A |
| LifeStance Health / TPG SPAC | Behavioral Health | 2,021 | PEAK | $7B | — | — | — | — | 15% | 75% | TPG / SPAC public | National | B |
| US Eye / Audax Private Equity | Ophthalmology | 2,021 | PEAK | $780M | 10.8x | — | — | — | 58% | 50% | Audax Private Equity | Southeast | A |
| The Oncology Institute / Advent International | Oncology | 2,021 | PEAK | $2B | 45.0x | 0.30x | — | 2.0 | 20% | 40% | Advent International | West Coast | A |
| Alignment Healthcare / Warburg Pincus → IPO | Medicare Advantage | 2,021 | PEAK | $4B | — | 1.20x | 6.0% | 3.0 | 15% | 8% | Public market investors | California | A |
| Greenbrook TMS – Mental Health Roll-Up (Distressed) | Behavioral Health | 2,021 | PEAK | $110M | 12.2x | 0.40x | -28.0% | 2.5 | 72% | 55% | CDPQ / FFL Partners | National | A |
| Caremax – Deerfield / SPAC Distressed | Value-Based Care | 2,021 | PEAK | $420M | — | 0.10x | -55.0% | 2.5 | 80% | 10% | Deerfield Management | Southeast | B |
| Primoris Dental – OMERS / Platform | Dental | 2,021 | PEAK | $130M | 9.3x | — | — | — | 52% | 72% | OMERS Private Equity | Midwest | B |
| Smile Brands – Berkshire Partners recapitalization | Dental | 2,021 | PEAK | $900M | 12.5x | 2.50x | 26.0% | 4.0 | — | 68% | Berkshire Partners | West | A |
| Pediatrix Medical Group – CCMP Capital | Physician Practice | 2,021 | PEAK | $3B | 10.7x | 2.20x | 22.0% | 4.0 | 60% | 50% | CCMP Capital | National | A |
| OrthoConnecticut – Revelstoke Capital | Orthopedics | 2,021 | PEAK | $250M | 8.9x | 3.50x | 38.0% | 3.5 | — | 72% | Revelstoke Capital | Northeast | A |
| CRH Medical – Ares Management take-private | Gastroenterology | 2,021 | PEAK | $830M | 10.4x | 2.60x | 30.0% | 3.5 | 60% | 60% | Ares Management | National | A |
| Atrium Health + Wake Forest Baptist Medical Center | — | 2,020 | CONTRACTION | $6B | 13.1x | — | — | — | — | 36% | Atrium Health | — | C |
| MultiPlan – Churchill Capital SPAC Merger | — | 2,020 | CONTRACTION | $11B | 12.9x | 3.20x | 24.0% | 6.0 | — | 100% | Churchill Capital Corp III (SP | — | B |
| Acuity Healthcare – HHS Acute Care Community Platform | — | 2,020 | CONTRACTION | $350M | 9.2x | — | — | — | — | 28% | Acuity Healthcare LP (family o | — | C |
| MEDNAX – Radiology Segment Sale to Envision / PE | — | 2,020 | CONTRACTION | $885M | 8.4x | — | — | — | — | — | Radiology Partners / Welsh Car | — | C |
| Privia Health Group – Advent International | — | 2,020 | CONTRACTION | $2B | 29.1x | 3.10x | 33.0% | 4.0 | — | — | Advent International / IPO | — | B |
| MEDNAX Radiology / Radiology Partners split-off | — | 2,020 | CONTRACTION | $885M | 10.4x | — | — | — | — | — | New Mountain Capital / MEDNAX | — | C |
| Premise Health – Warburg Pincus (employer health centers) | — | 2,020 | CONTRACTION | $1B | 12.6x | — | — | — | — | — | Warburg Pincus | — | C |
| Teladoc Health – Livongo Acquisition | — | 2,020 | CONTRACTION | $18B | — | — | — | — | — | — | Teladoc Health (TDOC) | — | D |
| InfuSystem Holdings – GTCR Acquisition | — | 2,020 | CONTRACTION | $340M | 8.9x | — | — | — | — | — | GTCR | — | C |
| Smile Brands – Gryphon Investors LBO | — | 2,020 | CONTRACTION | $480M | 8.7x | — | — | — | — | 58% | Gryphon Investors | — | C |
| US Renal Care – DaVita Acquisition (DOJ Blocked) | — | 2,020 | CONTRACTION | $2B | 12.2x | — | — | — | — | 14% | DaVita | — | C |
| Mednax Radiology Solutions – Radiology Partners Carve-out | — | 2,020 | CONTRACTION | $885M | 10.1x | — | — | — | — | 50% | Radiology Partners | — | C |
| Paradigm Oral Surgery – Cressey & Company Platform Creation | — | 2,020 | CONTRACTION | $290M | 9.1x | — | — | — | — | 65% | Cressey & Company | — | C |
| Acuity Eye Group – FFL Partners Platform | — | 2,020 | CONTRACTION | $380M | 9.0x | — | — | — | — | 44% | FFL Partners | — | C |
| Upstream Rehabilitation – Goldner Hawn / GTCR | — | 2,020 | CONTRACTION | $700M | 10.8x | — | — | — | — | 62% | GTCR | — | C |
| Pediatric Associates – KKR Platform Investment | — | 2,020 | CONTRACTION | $600M | 10.9x | — | — | — | — | 45% | KKR | — | C |
| Integrated Oncology Network – BDT Capital Platform | — | 2,020 | CONTRACTION | $520M | 9.5x | — | — | — | — | 37% | BDT Capital Partners | — | C |
| Tivity Health – Foley & Lardner / Spire Capital LBO | — | 2,020 | CONTRACTION | $660M | 7.8x | 2.30x | 19.0% | 3.0 | — | 13% | Spire Capital Partners | — | B |
| Paladina Health – DaVita Primary Care Spin / Village MD | — | 2,020 | CONTRACTION | $350M | — | 1.80x | 20.0% | 3.0 | — | 60% | Various (management buyout) | — | B |
| Fresenius Medical Care – NephroCare Dialysis Add-ons | — | 2,020 | CONTRACTION | $950M | 10.8x | — | — | — | — | 12% | Fresenius Medical Care | — | C |
| Behavioral Health Group – Webster Equity Platform LBO | — | 2,020 | CONTRACTION | $400M | 8.9x | — | — | — | — | 30% | Webster Equity Partners | — | C |
| Advanced Dermatology / L Catterton | — | 2,020 | CONTRACTION | $950M | 11.2x | 3.20x | 34.0% | 4.0 | — | 58% | L Catterton Partners | Southeast | B |
| Quorum Health / Bankruptcy Acquisition | — | 2,020 | CONTRACTION | $250M | 12.5x | 0.70x | -12.0% | 3.0 | — | 20% | Various (credit bidders) | Southeast | B |
| VITAS Healthcare / Chemed | — | 2,020 | CONTRACTION | $3B | 10.3x | — | — | — | — | 2% | Chemed Corporation | National | B |
| WellCare Health Plans / Centene Acquisition | — | 2,020 | CONTRACTION | $17B | 15.7x | — | — | — | — | 2% | Centene Corporation | National | B |
| Essentia Health / Rural Minnesota System | — | 2,020 | CONTRACTION | $800M | 14.5x | — | — | — | — | 22% | Essentia Health | Midwest | B |
| Diplomat Pharmacy / UnitedHealth OptumRx | — | 2,020 | CONTRACTION | $300M | 20.0x | — | — | 1.0 | — | 53% | UnitedHealth / OptumRx | Midwest | B |
| Behavioral Health Group / Shore Capital | — | 2,020 | CONTRACTION | $220M | 11.0x | 4.20x | 38.0% | 5.0 | — | 45% | Shore Capital Partners | Southeast | B |
| TeamHealth / Blackstone Secondary | — | 2,020 | CONTRACTION | $6B | 12.9x | 2.50x | 20.0% | 5.0 | — | 43% | Blackstone (secondary from Bla | National | B |
| United Urology Group / Frazier Healthcare | — | 2,020 | CONTRACTION | $380M | 10.9x | — | — | 5.0 | — | 38% | Frazier Healthcare Partners | Mid-Atlantic | B |
| Veracyte / PE Growth Investment | — | 2,020 | CONTRACTION | $800M | — | 5.50x | 53.0% | 4.0 | — | 48% | Various PE (growth round) | National | C |
| BrightSpring Home Services / KKR Add-Ons | — | 2,020 | CONTRACTION | $400M | 13.3x | — | — | 2.0 | — | 8% | KKR / BrightSpring | Midwest | B |
| Arcadia / Warburg Pincus | — | 2,020 | CONTRACTION | $500M | 14.3x | — | — | 4.0 | — | — | Warburg Pincus | National | C |
| National Spine & Pain Centers / Excellere Partners | — | 2,020 | CONTRACTION | $280M | 10.0x | — | — | 5.0 | — | 50% | Excellere Partners | Mid-Atlantic | B |
| Talkspace / PE Pre-IPO Investment | — | 2,020 | CONTRACTION | $400M | — | 0.60x | -22.0% | 2.0 | — | 75% | Various PE (pre-SPAC) | National | C |
| SpineMark / Revelstoke Capital | — | 2,020 | CONTRACTION | $320M | 10.7x | — | — | 5.0 | — | 45% | Revelstoke Capital Partners | Midwest | B |
| InVivo Therapeutics / PACE Acquisition | — | 2,020 | CONTRACTION | $150M | 12.5x | 2.80x | 23.0% | 5.0 | — | 0% | CareCore National / InVivo | Northeast | B |
| Pacific Dental Services / Warburg Pincus | — | 2,020 | CONTRACTION | $2B | 12.9x | — | — | 5.0 | — | 68% | Warburg Pincus | West | B |
| Silverado Senior Living / Summit Healthcare REIT | — | 2,020 | CONTRACTION | $450M | 11.8x | — | — | — | — | 8% | Summit Healthcare REIT | West | B |
| Healthcare Fund LP Secondary / Lexington Partners | — | 2,020 | CONTRACTION | $600M | 10.9x | 2.30x | 27.0% | 3.0 | — | — | Lexington Partners | National | B |
| Modivcare / Providence Service Corp Rebranding | — | 2,020 | CONTRACTION | $1B | 13.3x | — | — | — | — | 10% | Public (Nasdaq: MODV) | National | B |
| RxBenefits / Welsh Carson | — | 2,020 | CONTRACTION | $650M | 11.8x | — | — | 5.0 | — | — | Welsh Carson Anderson & Stowe | Southeast | C |
| Livongo Health / Teladoc Merger | — | 2,020 | CONTRACTION | $18B | — | 0.30x | -45.0% | 2.0 | — | 80% | Teladoc Health | National | C |
| Falck / US EMS Expansion | — | 2,020 | CONTRACTION | $800M | 12.3x | — | — | — | — | 30% | Falck Group (Danish) | National | B |
| Cornerstone OnDemand / Healtheon Telehealth Growth Equity | telehealth | 2,020 | CONTRACTION | $320M | — | 1.80x | 22.0% | 3.0 | — | 60% | TA Associates | — | C |
| CarepathRx Specialty Pharmacy Joint Venture | pharmacy / specialty pharmacy | 2,020 | CONTRACTION | $275M | 13.2x | 3.00x | 26.0% | 4.0 | — | 48% | Warburg Pincus | — | A |
| One Medical / Agilon Primary Care Platform | primary_care | 2,020 | CONTRACTION | $3B | — | 3.20x | 26.0% | 5.0 | — | 65% | Public IPO (One Medical) / var | — | B |
| Pediatric Associates / Centerbridge + Humana JV | pediatrics | 2,020 | CONTRACTION | $2B | 18.0x | — | — | — | — | 55% | Centerbridge Partners / Humana | — | B |
| Acuitas Health / WCAS physician enablement platform | value_based_care | 2,020 | CONTRACTION | $450M | — | — | — | — | — | 28% | Welsh Carson Anderson & Stowe | — | D |
| Lifespace Communities / Ryan Companies senior living | senior_living | 2,020 | CONTRACTION | $850M | 13.1x | 2.10x | 16.0% | 4.0 | — | 5% | Ryan Companies / Welltower REI | — | A |
| Adreima / Revenue Cycle Management add-on (Ensemble Health) | rcm | 2,020 | CONTRACTION | $2B | 20.0x | — | — | — | — | — | Ensemble Health Partners / Gol | — | C |
| Altus Healthcare + Rehab / Revelstoke Capital add-on | physical_therapy | 2,020 | CONTRACTION | $180M | 10.0x | 2.80x | 23.0% | 4.0 | — | 58% | Revelstoke Capital Partners | — | A |
| Acuity Brands Healthcare / Industrial lighting spin | ltach_post_acute | 2,020 | CONTRACTION | $800M | 8.0x | 2.30x | 18.0% | 4.0 | — | 13% | TPG Capital / Searchlight Capi | — | A |
| WellCare / Centene merger (second deal) | managed_care | 2,020 | CONTRACTION | $17B | 16.0x | 3.20x | 26.0% | 4.0 | — | 6% | Centene Corporation | — | A |
| Tivity Health / Donaldson Lufkin Jenrette secondary | digital_health | 2,020 | CONTRACTION | $660M | 8.5x | 2.50x | 20.0% | 4.0 | — | 14% | Marlin Equity Partners | — | A |
| IPC Systems / CareMore merger (telehealth ICU era) | telehealth | 2,020 | CONTRACTION | $1B | — | 2.00x | 14.0% | 5.0 | — | 45% | Teladoc Health | — | B |
| Caliber Imaging / pathology AI growth equity | diagnostics | 2,020 | CONTRACTION | $450M | — | — | — | — | — | 45% | General Atlantic / Bessemer Ve | — | D |
| Apria Healthcare — Blackstone Take-Private (2nd) | dme_home_health | 2,020 | CONTRACTION | $2B | 9.1x | 2.10x | 46.0% | 2.0 | — | 28% | Blackstone Group | — | A |
| Acute Care Staffing (AMN Healthcare) — AMN Acquisition | health_it | 2,020 | CONTRACTION | $330M | 9.4x | — | — | — | — | 55% | AMN Healthcare (Public) | — | B |
| ModivCare (Providence Service) — HCBS Platform | home_health | 2,020 | CONTRACTION | $1B | 10.5x | 2.50x | 36.0% | 3.0 | — | 22% | ModivCare Management (strategi | — | A |
| AFC Urgent Care — Warburg Pincus Investment | urgent_care | 2,020 | CONTRACTION | $450M | 11.2x | 3.50x | 37.0% | 4.0 | — | 62% | Warburg Pincus | — | A |
| LIFE Course (Enable Healthcare) — Summit Partners Growth | managed_care | 2,020 | CONTRACTION | $400M | 13.3x | — | — | — | — | 10% | Summit Partners | — | B |
| Teladoc Health — Blackstone / HHBF Acquisition | health_it | 2,020 | CONTRACTION | $18B | 92.5x | 0.20x | — | 3.0 | — | 75% | Teladoc Health (NASDAQ: TDOC) | — | B |
| Compassus — Warburg Pincus Majority Investment | hospice | 2,020 | CONTRACTION | $1B | 10.0x | 3.20x | 38.0% | 4.0 | — | 6% | Warburg Pincus (secondary with | — | A |
| Aledade — Andreessen Horowitz / Health Care Service | managed_care | 2,020 | CONTRACTION | $3B | 37.5x | — | — | — | — | 18% | a16z / HCSC / Alphabet Venture | — | B |
| aptihealth — Nuvation Growth Fund / VCAS | behavioral_health | 2,020 | CONTRACTION | $200M | — | — | — | — | — | 40% | Nuvation Growth Fund / Welsh C | — | D |
| Acuitas Health — Symphony Health / IQVia | health_it | 2,020 | CONTRACTION | $210M | 9.5x | 3.00x | 44.0% | 3.0 | — | 65% | Symphony Health / IQVIA | — | A |
| DispatchHealth — Echo Health Ventures / Humana | managed_care | 2,020 | CONTRACTION | $700M | — | — | — | — | — | 30% | Echo Health Ventures / Humana | — | D |
| Trean Corporation — Insurance Specialty Health | managed_care | 2,020 | CONTRACTION | $600M | 9.2x | 2.50x | 20.0% | 5.0 | — | 82% | Public / Sponsor Partial Exit | — | A |
| naviHealth — Optum Acquisition | health_it | 2,020 | CONTRACTION | $2B | 13.9x | 3.20x | 26.0% | 5.0 | — | 18% | Optum / UnitedHealth | — | A |
| Comprehensive Pharmacy Services / OMERS | Specialty Pharmacy | 2,020 | CONTRACTION | $520M | 9.0x | 3.10x | 33.0% | 4.0 | 55% | 35% | OMERS Private Equity | National | A |
| Arcadian Management Services / Nautic Partners | Behavioral Health | 2,020 | CONTRACTION | $320M | 9.1x | 3.80x | 56.0% | 3.0 | 52% | 25% | Nautic Partners | Southeast | A |
| OrthoAmerica Spine / Clearfield Capital | Orthopedics | 2,020 | CONTRACTION | $320M | 8.4x | 3.20x | 47.0% | 3.0 | 52% | 62% | Clearfield Capital | Southeast | A |
| Radiology Partners / New Enterprise Associates II | Radiology | 2,020 | CONTRACTION | $3B | 16.7x | — | — | — | 65% | 50% | New Enterprise Associates | National | A |
| PatientPoint / Warburg Pincus | Health IT | 2,020 | CONTRACTION | $600M | 10.0x | — | — | — | 45% | 100% | Warburg Pincus | National | A |
| Pediatric Associates – KKR Platform | Pediatrics | 2,020 | CONTRACTION | $820M | 11.4x | 2.60x | 27.0% | 4.0 | 60% | 55% | KKR | Southeast | A |
| Navvis & Company – Health System Consulting LBO | Healthcare Consulting | 2,020 | CONTRACTION | $75M | 8.3x | 2.90x | 36.0% | 3.5 | 45% | 65% | Summit Partners | Midwest | A |
| American Physician Partners – Distressed Exit | Emergency Medicine | 2,020 | CONTRACTION | $350M | 12.5x | 0.60x | -18.0% | 2.8 | 72% | 42% | TPG Capital | National | A |
| Advanced Dermatology – ACON / GIC Roll-Up | Dermatology | 2,020 | CONTRACTION | $480M | 11.4x | — | — | — | 58% | 65% | ACON Investments / GIC | National | B |
| Hims & Hers – Oaktree / Pre-SPAC | Telehealth / DTC | 2,020 | CONTRACTION | $165M | — | 3.60x | 82.0% | 2.0 | 15% | 35% | Oaktree Capital | National | B |
| Schweiger Dermatology – InTandem Capital | Dermatology | 2,020 | CONTRACTION | $380M | 10.0x | 3.40x | 31.0% | 4.5 | 52% | 82% | InTandem Capital | Northeast | A |
| Women's Health USA – Frazier Healthcare Partners | Women's Health | 2,020 | CONTRACTION | $320M | 10.7x | 3.20x | 29.0% | 4.5 | — | 70% | Frazier Healthcare Partners | Northeast | A |
| Gastro Health – KKR add-on platform | Gastroenterology | 2,020 | CONTRACTION | $1B | 11.6x | 2.90x | 30.0% | 4.0 | 58% | 58% | KKR | Southeast | A |
| BrightSpring Health Services – KKR Platform | — | 2,019 | EXPANSION | $2B | 12.8x | 1.90x | 14.0% | 5.0 | — | 18% | KKR | — | B |
| CommonSpirit Health – Dignity Health + CHI Merger | — | 2,019 | EXPANSION | $29B | 16.1x | — | — | — | — | 36% | CommonSpirit Health (combined | — | C |
| PHC Inc / Behavioral Health Network – Sequel Youth and Family Services | — | 2,019 | EXPANSION | $180M | 8.2x | — | — | — | — | 30% | Sequel Youth & Family Services | — | C |
| RCCH HealthCare Partners + LifePoint Health Merger | — | 2,019 | EXPANSION | $8B | 11.1x | — | — | — | — | 29% | LifePoint Health (KKR) | — | C |
| BrightSpring Health Services – KKR | — | 2,019 | EXPANSION | $2B | 10.0x | 1.80x | 13.0% | 4.5 | — | — | KKR | — | B |
| Tivity Health – Welsh Carson Buyout | — | 2,019 | EXPANSION | $635M | 6.7x | 1.40x | 10.0% | 3.5 | — | — | Welsh Carson Anderson & Stowe | — | B |
| Civitas Solutions / Public Shareholders | — | 2,019 | EXPANSION | $1B | 8.8x | — | — | — | — | — | A-G Capital Partners (manageme | — | C |
| Centurion Health – American Securities acquisition | — | 2,019 | EXPANSION | $320M | 10.0x | — | — | — | — | — | American Securities | — | C |
| Option Care Health – Walgreens Infusion Services Carve-out | — | 2,019 | EXPANSION | $580M | 12.1x | 2.80x | 24.0% | 3.5 | — | 50% | Option Care Health | — | B |
| SurgCenter Development / Warburg Pincus | — | 2,019 | EXPANSION | $450M | 11.2x | 3.80x | 31.0% | 5.0 | — | 56% | Warburg Pincus | Southeast | B |
| UCSF Benioff Children's / Joint Venture | — | 2,019 | EXPANSION | $400M | — | — | — | — | — | 44% | Dignity Health (JV partner) | West | D |
| InnovaCare Health / TPG | — | 2,019 | EXPANSION | $1B | 12.2x | 2.80x | 23.0% | 5.0 | — | 2% | TPG Capital | Southeast | B |
| Elara Caring / BPEA | — | 2,019 | EXPANSION | $1B | 13.3x | 2.10x | 16.0% | 5.0 | — | 8% | BPEA (formerly BPEA EQT) | Midwest | B |
| Centurion Health / Wexford Health Merger | — | 2,019 | EXPANSION | $300M | 10.7x | 2.40x | 19.0% | 5.0 | — | 0% | MHM Services (operator) | National | B |
| BioScrip / Option Care (Merger) | — | 2,019 | EXPANSION | $2B | 15.7x | 3.10x | 33.0% | 4.0 | — | 55% | Option Care Health (post-merge | National | B |
| ChenMed / Frist Cressey Growth Investment | — | 2,019 | EXPANSION | $1B | 14.3x | — | — | 4.0 | — | 5% | Frist Cressey Ventures | Southeast | B |
| Parallon / HCA Spin-Out | — | 2,019 | EXPANSION | $2B | 11.1x | — | — | — | — | — | Parallon (HCA captive → extern | Southeast | C |
| Prime Therapeutics / BCBS PBM JV | — | 2,019 | EXPANSION | $2B | 12.5x | — | — | — | — | 70% | BCBS Plans (JV owner) | National | B |
| AdaptHealth / Goldman Sachs BDC | — | 2,019 | EXPANSION | $900M | 12.9x | 2.00x | 26.0% | 3.0 | — | 22% | AdaptHealth (SPAC acquisition) | National | B |
| Healogics / Arsenal Capital | — | 2,019 | EXPANSION | $750M | 12.5x | 2.90x | 24.0% | 5.0 | — | 21% | Arsenal Capital Partners | National | B |
| Waystar / EQT | — | 2,019 | EXPANSION | $3B | 13.5x | — | — | 5.0 | — | — | EQT Partners | National | C |
| NVA (National Veterinary Associates) / JAB Holding | — | 2,019 | EXPANSION | $3B | 13.2x | 3.00x | 25.0% | 5.0 | — | 20% | JAB Holding Company | National | B |
| HearingLife / Demant | — | 2,019 | EXPANSION | $600M | 12.5x | — | — | — | — | 30% | Demant (Danish hearing aid com | National | B |
| CCRM / Weinberg Capital | — | 2,019 | EXPANSION | $500M | 11.1x | 3.50x | 29.0% | 5.0 | — | 45% | Weinberg Capital Group | National | B |
| CommonWell Health Alliance / HIT Infrastructure | — | 2,019 | EXPANSION | $300M | 13.6x | — | — | — | — | — | Various health IT consortia | National | C |
| Outset Medical / PE Growth Round | — | 2,019 | EXPANSION | $500M | — | 4.50x | 65.0% | 3.0 | — | 16% | Various PE (Series D) | National | C |
| Sonic Healthcare / Pathology Australia Expansion | — | 2,019 | EXPANSION | $900M | 10.6x | — | — | — | — | 33% | Sonic Healthcare | National | B |
| Sequel Youth and Family Services / Juggernaut Capital | — | 2,019 | EXPANSION | $280M | 10.0x | — | — | 4.0 | — | 30% | Juggernaut Capital Partners | National | B |
| NextCare Urgent Care / Wellspring Capital | — | 2,019 | EXPANSION | $550M | 11.5x | 3.00x | 25.0% | 5.0 | — | 64% | Wellspring Capital Management | Southwest | B |
| Accolade Health / PE Pre-IPO Round | — | 2,019 | EXPANSION | $600M | — | 3.80x | 87.0% | 2.0 | — | — | Various PE (pre-IPO) | National | C |
| Optum / DaVita Medical Group | — | 2,019 | EXPANSION | $5B | 12.9x | — | — | — | — | 33% | UnitedHealth / Optum | West | B |
| GoHealth / Centerbridge Partners | — | 2,019 | EXPANSION | $2B | 10.0x | 1.30x | 14.0% | 2.0 | — | 0% | Centerbridge Partners | National | B |
| iRhythm Technologies / Pre-IPO Round | — | 2,019 | EXPANSION | $600M | — | 5.00x | 124.0% | 2.0 | — | 50% | Various PE (Series E) | National | C |
| Smile Brands Dental Group Recapitalization | dental | 2,019 | EXPANSION | $680M | 12.4x | 1.20x | 6.0% | 4.0 | — | 55% | Gryphon Investors | — | A |
| National Veterinary Associates Add-On to QVCP | veterinary (animal health) | 2,019 | EXPANSION | $2B | 18.5x | 3.80x | 31.0% | 4.0 | — | — | KKR | — | B |
| BrightSpring Health Services Home & Community Care LBO | home health / community-based care | 2,019 | EXPANSION | $1B | 10.8x | 2.60x | 21.0% | 4.5 | — | 18% | KKR | — | A |
| Women's Care Enterprises OB/GYN Rollup | women's health | 2,019 | EXPANSION | $95M | 9.5x | 5.10x | 43.0% | 4.0 | — | 60% | Shore Capital Partners | — | A |
| Behavioral Health Group / Frontenac add-on acquisition | behavioral_health | 2,019 | EXPANSION | $85M | 8.5x | 3.40x | 28.0% | 4.0 | — | 30% | Frontenac Company | — | A |
| TridentCare / Gridiron Capital LBO | mobile_diagnostics | 2,019 | EXPANSION | $475M | 13.0x | 3.50x | 30.0% | 4.0 | — | 17% | Gridiron Capital | — | A |
| US Physical Therapy / Kelso & Company add-on wave | physical_therapy | 2,019 | EXPANSION | $700M | 14.0x | 1.60x | 11.0% | 4.0 | — | 55% | Kelso & Company | — | A |
| DaVita Medical Group / Optum carve-out (VillageMD era) | primary_care | 2,019 | EXPANSION | $5B | 25.0x | 3.50x | 29.0% | 4.0 | — | 8% | Optum / UnitedHealth Group | — | A |
| Pivot Health / Deerfield acquisition + platform build | managed_care | 2,019 | EXPANSION | $180M | — | 2.00x | 15.0% | 4.0 | — | 75% | Deerfield Management | — | B |
| Surgical Directions / Waud Capital LBO | asc | 2,019 | EXPANSION | $200M | 11.8x | 3.80x | 33.0% | 4.0 | — | 65% | Waud Capital Partners | — | A |
| BioSig Technologies / cardiac electrophysiology growth | cardiology | 2,019 | EXPANSION | $200M | — | 0.40x | -18.0% | 5.0 | — | 42% | Multiple VC / Windtree Therape | — | B |
| Navicent Health / Atrium Health merger | hospital | 2,019 | EXPANSION | $1B | 8.0x | 2.00x | 14.0% | 5.0 | — | 25% | Atrium Health | — | A |
| CHC Healthcare / CareFlight Air Medical acquisition | ems | 2,019 | EXPANSION | $3B | 11.0x | 1.80x | 12.0% | 5.0 | — | 30% | Global Medical Response (AMR/A | — | A |
| Fresenius Kabi / NxStage Medical acquisition | dialysis | 2,019 | EXPANSION | $2B | 25.0x | 3.80x | 31.0% | 5.0 | — | 10% | Fresenius Medical Care | — | A |
| Dermatology Associates / Harvest Partners roll-up | physician_group | 2,019 | EXPANSION | $350M | 10.0x | 3.80x | 32.0% | 4.0 | — | 65% | Harvest Partners | — | A |
| Cotiviti / Veritas Capital secondary (post-Healtheon) | health_it | 2,019 | EXPANSION | $5B | 24.0x | — | — | — | — | — | Carlyle Group | — | C |
| PharMerica / BrightSpring merger (KKR + Walgreens) | pharmacy | 2,019 | EXPANSION | $3B | 12.0x | 2.80x | 22.0% | 4.0 | — | 12% | KKR / Walgreens Boots Alliance | — | A |
| DaVita Medical Group — UnitedHealth Group Acquisition | physician_group | 2,019 | EXPANSION | $5B | 17.5x | — | — | — | — | 52% | UnitedHealth Group / Optum | — | B |
| BrightSpring Health Services — KKR Take-Private | home_health | 2,019 | EXPANSION | $1B | 10.0x | 2.80x | 22.0% | 5.0 | — | 12% | KKR | — | A |
| Smile Brands — OMERS / Gryphon Investors Buyout | dental | 2,019 | EXPANSION | $550M | 10.0x | 2.20x | 22.0% | 4.0 | — | 50% | OMERS Private Equity / Gryphon | — | A |
| National Mentor — Centerbridge / Vistria Group Acquisition | behavioral_health | 2,019 | EXPANSION | $2B | 11.0x | 3.20x | 26.0% | 5.0 | — | 15% | Centerbridge Partners / Vistri | — | A |
| Lifespace Communities — Senior Living REITization | snf | 2,019 | EXPANSION | $2B | 16.7x | — | — | — | — | 30% | Welltower / Lifespace JV | — | B |
| Option Care Health — HC Group Holdings / BioScrip Merger | dme_home_health | 2,019 | EXPANSION | $2B | 13.0x | 3.00x | 32.0% | 4.0 | — | 46% | Walgreens / Madison Dearborn ( | — | A |
| Summit Pacific Medical Center — Rural Hospital Distressed Sale | hospital | 2,019 | EXPANSION | $85M | 10.6x | 0.60x | — | 3.0 | — | 16% | Quorum Health Group | — | B |
| American Family Care — Deerfield Management Investment | urgent_care | 2,019 | EXPANSION | $540M | 11.2x | 3.00x | 32.0% | 4.0 | — | 60% | Deerfield Management | — | A |
| Shields Health Solutions — Oak HC/FT Buyout | health_it | 2,019 | EXPANSION | $320M | 10.7x | 5.00x | 71.0% | 3.0 | — | 55% | Oak HC/FT | — | A |
| Surgical Notes — Providence Equity Buyout | health_it | 2,019 | EXPANSION | $230M | 9.2x | 4.00x | 41.0% | 4.0 | — | 48% | Providence Equity Partners | — | A |
| Sutter Health / Catholic Health — Non-Profit Benchmark | hospital | 2,019 | EXPANSION | $6B | 17.1x | — | — | — | — | 34% | N/A (not-for-profit affiliatio | — | B |
| Viant Medical / Integer Holdings — Medical Device Mfg LBO | health_it | 2,019 | EXPANSION | $850M | 8.9x | 2.20x | 22.0% | 4.0 | — | 55% | Clayton Dubilier & Rice | — | A |
| Beacon Health Options — FCP Euro / Anthem | behavioral_health | 2,019 | EXPANSION | $1B | 10.5x | 2.50x | 20.0% | 5.0 | — | 30% | Anthem (BCBS) | — | A |
| Global Indemnity Group — Starr Companies Acquisition | managed_care | 2,019 | EXPANSION | $690M | 10.6x | — | — | — | — | 90% | Starr Companies | — | B |
| Central Logic / Appriss Health — Roper Technologies | health_it | 2,019 | EXPANSION | $1B | 10.8x | 3.00x | 25.0% | 5.0 | — | 45% | Roper Technologies (Public, NA | — | A |
| Tivity Health (Healthways) — Kelso & Company | managed_care | 2,019 | EXPANSION | $700M | 9.3x | 1.50x | 11.0% | 4.0 | — | 16% | Kelso & Company | — | A |
| Oak Street Health — General Atlantic / Anchor Growth | managed_care | 2,019 | EXPANSION | $3B | 33.8x | 2.80x | 68.0% | 2.0 | — | 3% | General Atlantic (secondary) | — | A |
| NovaBay / Wellvibe — Wound Care Rx | physician_group | 2,019 | EXPANSION | $180M | 10.0x | 3.50x | 37.0% | 4.0 | — | 25% | Woundtech / WCAS | — | A |
| DocuSystems / Nuvolo — HCIT CMMS Platforms | health_it | 2,019 | EXPANSION | $300M | 10.7x | 4.00x | 41.0% | 4.0 | — | 70% | Warburg Pincus | — | A |
| myClinicalExchange — HealthStream Acquisition | health_it | 2,019 | EXPANSION | $90M | 9.0x | — | — | — | — | 60% | HealthStream (NASDAQ: HSTM) | — | B |
| Covenant Physician Partners / Quad-C | Anesthesiology | 2,019 | EXPANSION | $450M | 8.7x | 4.20x | 61.0% | 3.0 | 55% | 60% | Quad-C Management | Southeast | A |
| BrightSpring Health Services / KKR | Home & Community Health | 2,019 | EXPANSION | $3B | 11.4x | 1.80x | 12.0% | 5.0 | 65% | 15% | KKR | National | A |
| National Spine & Pain Centers / Waud Capital | Pain Management | 2,019 | EXPANSION | $680M | 9.4x | 3.40x | 50.0% | 3.0 | 57% | 55% | Waud Capital Partners | Mid-Atlantic | A |
| Waystar / EQT Partners | Revenue Cycle Management | 2,019 | EXPANSION | $3B | 12.3x | 3.80x | 31.0% | 5.0 | 58% | 65% | EQT Partners | National | A |
| EyeCare Partners / FFL Partners II | Ophthalmology | 2,019 | EXPANSION | $2B | 11.5x | — | — | — | 60% | 55% | FFL Partners | National | A |
| Shields Health Solutions / Summit Partners exit | Specialty Pharmacy | 2,019 | EXPANSION | $600M | 10.0x | 5.00x | 124.0% | 2.0 | 45% | 55% | Summit Partners | National | A |
| InfuSystem / BCPE Empire Holdings | Home Infusion | 2,019 | EXPANSION | $460M | 8.4x | — | — | — | 60% | 45% | BCPE Empire Holdings (Bain Cap | National | A |
| ChenMed / Welsh Carson | Primary Care | 2,019 | EXPANSION | $2B | 15.0x | — | — | — | 30% | 10% | Welsh Carson Anderson & Stowe | Southeast | A |
| Agiliti / Thomas H. Lee Partners | Healthcare Equipment Services | 2,019 | EXPANSION | $1B | 10.0x | 2.90x | 30.0% | 4.0 | 58% | 55% | Thomas H. Lee Partners | National | A |
| NovaBay Pharmaceuticals – THL Partners RCM Carve-Out | Healthcare IT / RCM | 2,019 | EXPANSION | $90M | 8.6x | 2.20x | 24.0% | 3.8 | 55% | 72% | THL Partners | West | A |
| Covenant Physician Partners – Warburg Pincus Hospital-Based | Hospital-Based Physician Groups | 2,019 | EXPANSION | $650M | 11.8x | 3.20x | 35.0% | 4.2 | 58% | 48% | Warburg Pincus | Southeast | A |
| Phreesia – PSG / SaaS Healthcare | Healthcare IT / RCM | 2,019 | EXPANSION | $300M | 15.0x | 4.80x | 67.0% | 3.0 | 20% | 85% | PSG Equity (Growth) | Northeast | A |
| Aspen Dental – Ontario Teachers / Leonard Green LBO | Dental | 2,019 | EXPANSION | $2B | 14.2x | 3.10x | 25.0% | 5.0 | 58% | 72% | Ontario Teachers / Leonard Gre | National | A |
| Eye Health America – Quad-C Management LBO | Ophthalmology | 2,019 | EXPANSION | $200M | 11.1x | 3.00x | 32.0% | 4.0 | — | 48% | Quad-C Management | Southeast | A |
| US Fertility – Amulet Capital Partners platform | Fertility | 2,019 | EXPANSION | $550M | 10.0x | 3.20x | 34.0% | 4.0 | 52% | 80% | Amulet Capital Partners | National | A |
| National Spine & Pain Centers – Blue Wolf Capital | Pain Management | 2,019 | EXPANSION | $240M | 10.0x | 2.70x | 28.0% | 4.0 | — | 55% | Blue Wolf Capital | Mid-Atlantic | A |
| Envision Healthcare – KKR Buyout | — | 2,018 | EXPANSION | $10B | 14.6x | 0.05x | -44.0% | 5.0 | — | 36% | KKR | — | B |
| LifePoint Health – KKR Buyout | — | 2,018 | EXPANSION | $6B | 9.0x | — | — | — | — | 29% | KKR | — | C |
| Kindred Healthcare – TPG / Welsh Carson / Humana Buyout | — | 2,018 | EXPANSION | $4B | 12.8x | 1.40x | 12.0% | 3.0 | — | 19% | TPG Capital / Welsh Carson / H | — | B |
| Advocate Health + Aurora Health Care Merger | — | 2,018 | EXPANSION | $11B | 10.5x | — | — | — | — | 42% | Advocate Aurora Health (combin | — | C |
| Encompass Health – HealthSouth Rehabilitation Rebranding / PE Exit | — | 2,018 | EXPANSION | $7B | 8.3x | — | — | — | — | 20% | Public shareholders (NYSE: EHC | — | C |
| Kindred at Home – TPG / Welsh Carson Partial Exit via JV with Humana | — | 2,018 | EXPANSION | $4B | 14.3x | — | — | 3.0 | — | 18% | Humana (40% JV stake) | — | B |
| Sound Physicians – TPG Capital Buyout | — | 2,018 | EXPANSION | $2B | 12.2x | — | — | — | — | 30% | TPG Capital | — | C |
| Kindred Healthcare 2 – TPG/Welsh Carson/Humana | — | 2,018 | EXPANSION | $4B | 10.0x | — | — | — | — | — | TPG / Welsh Carson / Humana | — | C |
| Mountain States Health Alliance + Wellmont → Ballad Health | — | 2,018 | EXPANSION | $3B | 15.6x | — | — | — | — | — | Not-for-profit merger | — | C |
| Envision Healthcare – KKR Take-Private | — | 2,018 | EXPANSION | $10B | 11.0x | 0.20x | -28.0% | 5.0 | — | — | KKR | — | B |
| LifePoint Health – RCCH HealthCare Partners Merger | — | 2,018 | EXPANSION | $6B | 10.0x | — | — | — | — | — | Apollo Global / RCCH | — | C |
| Heartland Dental / KKR | — | 2,018 | EXPANSION | $3B | 16.0x | — | — | 5.0 | — | 68% | KKR | Midwest | B |
| Evernorth / Express Scripts (Cigna) | — | 2,018 | EXPANSION | $67B | 12.9x | — | — | — | — | — | Cigna Group | National | C |
| Rural Metro / KKR Exit to AMR | — | 2,018 | EXPANSION | $2B | 11.7x | 2.20x | 17.0% | 5.0 | — | 28% | American Medical Response | National | B |
| Allegheny Health Network / Highmark JV | — | 2,018 | EXPANSION | $1B | 15.0x | — | — | — | — | 32% | Highmark Health | Northeast | B |
| Ballad Health / Mountain States Health Alliance | — | 2,018 | EXPANSION | $2B | 13.8x | — | — | — | — | 20% | Ballad Health (merged entity) | Southeast | B |
| Radiology Partners / New Enterprise Associates | — | 2,018 | EXPANSION | $2B | 13.3x | — | — | 5.0 | — | 38% | New Enterprise Associates / St | National | B |
| Rotech Healthcare / PE Recapitalization | — | 2,018 | EXPANSION | $500M | 11.1x | 2.50x | 20.0% | 5.0 | — | 22% | Management + PE recapitalizati | National | B |
| Vanderbilt / Lifepoint Health Strategic Alliance | — | 2,018 | EXPANSION | $2B | 13.8x | — | — | — | — | 27% | LifePoint Health (RCCH) | Southeast | B |
| Pyramid Healthcare / Warburg Pincus | — | 2,018 | EXPANSION | $400M | 10.5x | 3.10x | 26.0% | 5.0 | — | 42% | Warburg Pincus | Northeast | B |
| RegionalCare Hospital Partners / LifePoint Merger | — | 2,018 | EXPANSION | $6B | 12.4x | 2.50x | 20.0% | 5.0 | — | 28% | LifePoint Health (merged) | National | B |
| Kindred at Home Hospice & Home Health Carve-Out | home health / hospice | 2,018 | EXPANSION | $1B | 11.8x | 3.40x | 28.0% | 4.5 | — | 14% | Welsh Carson Anderson & Stowe | — | A |
| Envision Healthcare Physician Staffing Merger | physician groups | 2,018 | EXPANSION | $10B | 13.5x | 0.10x | -45.0% | 5.0 | — | 50% | KKR | — | A |
| Lifepoint Health LTACH / Rehabilitation Secondary | LTACH / post-acute | 2,018 | EXPANSION | $6B | 8.5x | 2.20x | 17.0% | 5.0 | — | 24% | Apollo Global Management | — | A |
| Kindred Healthcare / TPG + Humana LBO | ltach_post_acute | 2,018 | EXPANSION | $4B | 10.8x | 2.60x | 19.0% | 4.0 | — | 12% | TPG Capital / Humana | — | A |
| Alignment Healthcare / General Atlantic growth equity | managed_care | 2,018 | EXPANSION | $750M | — | 3.80x | 32.0% | 4.0 | — | 0% | General Atlantic | — | C |
| Matrix Medical Network / Frazier Healthcare LBO | managed_care_services | 2,018 | EXPANSION | $625M | 12.5x | 4.00x | 34.0% | 4.0 | — | 20% | Frazier Healthcare Partners | — | A |
| American Vision Partners / Arizona Eye Consultants roll-up | ophthalmology | 2,018 | EXPANSION | $140M | 9.3x | 4.20x | 36.0% | 4.0 | — | 32% | MedEquity Capital | — | A |
| Greenway Health / Vista Equity take-private | health_it | 2,018 | EXPANSION | $2B | 20.0x | 2.30x | 17.0% | 5.0 | — | — | Vista Equity Partners | — | B |
| Smile Direct Club / Clayton Dubilier & Rice growth equity | dental | 2,018 | EXPANSION | $3B | — | 0.05x | -45.0% | 5.0 | — | 10% | Clayton Dubilier & Rice | — | B |
| ModivCare (Providence Service) / Coliseum Capital LBO | nemt | 2,018 | EXPANSION | $750M | 9.0x | 2.80x | 22.0% | 4.0 | — | 10% | Coliseum Capital Management | — | A |
| EXL Health / Outsourced RCM division growth | rcm | 2,018 | EXPANSION | $800M | 18.2x | 3.20x | 27.0% | 4.0 | — | — | EXL Service Holdings | — | B |
| Advanced ICU Care / WindRose Health Investors growth equity | health_it | 2,018 | EXPANSION | $200M | 15.4x | 4.10x | 35.0% | 4.0 | — | 28% | WindRose Health Investors | — | A |
| Sound Physicians / Summit Partners LBO | physician_group | 2,018 | EXPANSION | $2B | 14.0x | 3.00x | 24.0% | 5.0 | — | 33% | Summit Partners | — | A |
| National Health Investors / Senior Care REIT strategic acquisition | snf | 2,018 | EXPANSION | $250M | 8.1x | 1.80x | 12.0% | 5.0 | — | 12% | National Health Investors (NHI | — | A |
| Heritage Healthcare / ABRY Partners add-on roll-up | home_health | 2,018 | EXPANSION | $320M | 9.4x | 2.50x | 19.0% | 4.5 | — | 11% | ABRY Partners | — | A |
| LHC Group / Almost Family merger | home_health | 2,018 | EXPANSION | $2B | 13.9x | 3.00x | 24.0% | 5.0 | — | 11% | LHC Group (LHCG public) | — | A |
| Capio AB / Ramsay Health Care acquisition | hospital | 2,018 | EXPANSION | $4B | 12.0x | 2.80x | 22.0% | 5.0 | — | 55% | Ramsay Health Care | — | A |
| NovaBay Pharmaceuticals / Wound care spinout | hospital | 2,018 | EXPANSION | $85M | — | 0.40x | -15.0% | 5.0 | — | 45% | SWK Holdings / specialty finan | — | B |
| LifePoint Health / RCCH merge + Province Healthcare rollup | hospital | 2,018 | EXPANSION | $6B | 8.5x | 2.50x | 19.0% | 5.0 | — | 30% | Apollo Global Management | — | A |
| Molina Healthcare / Joseph Molina family buyout | managed_care | 2,018 | EXPANSION | $5B | 11.0x | 4.50x | 38.0% | 4.0 | — | 6% | Public company (NASDAQ: MOH) | — | A |
| Veritas Medical / Amsurg cardiology add-on | cardiology | 2,018 | EXPANSION | $425M | 12.1x | 3.20x | 27.0% | 4.0 | — | 33% | Carlyle Group / cardiovascular | — | A |
| National Staffing Group / healthcare staffing PE | managed_care_services | 2,018 | EXPANSION | $150M | 7.5x | 4.50x | 38.0% | 4.0 | — | — | Ridgemont Equity Partners | — | B |
| MedBridge / TA Associates physical therapy digital | digital_health | 2,018 | EXPANSION | $180M | — | 4.20x | 36.0% | 4.0 | — | 55% | TA Associates | — | B |
| GI Alliance / Ares Management + GI physician roll-up | gi | 2,018 | EXPANSION | $2B | 13.0x | — | — | — | — | 53% | Ares Management / Waud Capital | — | B |
| Pediatric Home Service / Stellus Capital specialty | home_health | 2,018 | EXPANSION | $90M | 8.2x | 3.30x | 28.0% | 4.5 | — | 9% | Stellus Capital Management | — | A |
| Amedisys / LHC Group strategic position building | home_health | 2,018 | EXPANSION | $2B | 15.9x | 3.50x | 29.0% | 4.0 | — | 12% | LHC Group / UnitedHealth Group | — | A |
| Envision Healthcare — KKR Take-Private (post-IPO re-LBO) | physician_group | 2,018 | EXPANSION | $10B | 11.6x | 0.10x | — | 5.0 | — | 46% | KKR | — | B |
| Kindred at Home — Humana Majority Buyout | home_health | 2,018 | EXPANSION | $4B | 12.1x | 2.40x | 26.0% | 3.0 | — | 16% | Humana / TPG Capital / WCAS | — | A |
| PharMerica — KKR Acquisition (from BrightSpring carve-out) | health_it | 2,018 | EXPANSION | $1B | 9.7x | 3.00x | 20.0% | 6.0 | — | 18% | KKR | — | A |
| Greenway Health — Vista Equity Buyout | health_it | 2,018 | EXPANSION | $2B | 11.3x | 2.50x | 20.0% | 5.0 | — | 70% | Vista Equity Partners | — | A |
| Gastro Health — Audax Private Equity Buyout | physician_group | 2,018 | EXPANSION | $270M | 9.6x | 4.50x | 45.0% | 4.0 | — | 38% | Audax Private Equity | — | A |
| Alignment Healthcare — General Atlantic Investment | managed_care | 2,018 | EXPANSION | $1B | 20.0x | 3.00x | 44.0% | 3.0 | — | 2% | General Atlantic | — | A |
| NovaBay Pharmaceuticals / Perrigo — Consumer Health Tuck-in | health_it | 2,018 | EXPANSION | $200M | 11.1x | — | — | — | — | 30% | Perrigo Company | — | B |
| Select Physical Therapy — Welsh Carson LBO | physical_therapy | 2,018 | EXPANSION | $900M | 10.6x | 2.50x | 20.0% | 5.0 | — | 41% | Welsh Carson Anderson & Stowe | — | A |
| Kindred Healthcare — Humana Full Acquisition | home_health | 2,018 | EXPANSION | $4B | 14.1x | — | — | — | — | 22% | Humana | — | B |
| Curation Health (formerly Medicomp) — TA Associates | health_it | 2,018 | EXPANSION | $180M | 9.0x | 4.50x | 35.0% | 5.0 | — | 25% | TA Associates | — | A |
| Sound Physicians — Fresenius Medical Care Acquisition | physician_group | 2,018 | EXPANSION | $2B | 12.9x | 3.50x | 25.0% | 6.0 | — | 30% | Fresenius Medical Care NA | — | A |
| Akumin — Imaging Tech LBO | radiology | 2,018 | EXPANSION | $650M | 10.0x | 0.60x | — | 5.0 | — | 39% | CBRE Caledon / Management | — | B |
| HealthMarket / eHealth — Insurance Distribution Platform | managed_care | 2,018 | EXPANSION | $1B | 11.1x | 2.20x | 22.0% | 4.0 | — | 52% | General Atlantic / Blackstone | — | A |
| American Addiction Centers — BlackRock / Deerfield | behavioral_health | 2,018 | EXPANSION | $700M | 10.8x | 0.40x | — | 3.0 | — | 48% | BlackRock / Deerfield Manageme | — | B |
| Recovery Centers of America — Healthcare Royalty Partners | behavioral_health | 2,018 | EXPANSION | $550M | 11.5x | 2.80x | 23.0% | 5.0 | — | 55% | Healthcare Royalty Partners / | — | A |
| Aveanna Healthcare — Bain Capital LBO | home_health | 2,018 | EXPANSION | $1B | 11.8x | 1.50x | 11.0% | 4.0 | — | 12% | Bain Capital | — | A |
| National Emergency Medical Services Authority — AMR | physician_group | 2,018 | EXPANSION | $2B | 13.3x | 2.00x | 19.0% | 4.0 | — | 40% | American Medical Response (KKR | — | A |
| ModivCare / WCG (exit via public markets) | NEMT / Transportation | 2,018 | EXPANSION | $400M | 8.3x | 3.50x | 52.0% | 3.0 | 50% | 10% | Public markets | National | A |
| Quartet Health / Oak HC/FT | Digital Health | 2,018 | EXPANSION | $220M | — | 2.00x | 19.0% | 4.0 | 10% | 65% | Oak HC/FT (growth) | National | A |
| LifeScan / Platinum Equity | Medical Devices | 2,018 | EXPANSION | $2B | 7.5x | 0.90x | — | 5.0 | 65% | 50% | Platinum Equity | Global | A |
| InnovAge Holding / Welsh Carson (PACE platform) | Senior Care / PACE | 2,018 | EXPANSION | $850M | 11.3x | 3.80x | 56.0% | 3.0 | 45% | 10% | Welsh Carson Anderson & Stowe | National | A |
| Kindred Healthcare / TPG + Welsh Carson | Post-Acute / LTAC | 2,018 | EXPANSION | $4B | 10.8x | 2.20x | 24.0% | 3.0 | 65% | 12% | TPG Capital + Welsh Carson | National | A |
| HealthChannels / ScribeAmerica – Warburg Pincus | Healthcare IT / RCM | 2,018 | EXPANSION | $420M | 11.1x | 3.30x | 33.0% | 4.5 | 52% | 80% | Warburg Pincus | National | A |
| Acuity Eye Group – Varsity Healthcare Partners | Ophthalmology | 2,018 | EXPANSION | $290M | 10.0x | 3.80x | 30.0% | 5.0 | 50% | 55% | Varsity Healthcare Partners | West | A |
| Unified Women's Healthcare – Welsh Carson LBO | Women's Health | 2,018 | EXPANSION | $780M | 12.0x | 3.00x | 25.0% | 5.0 | 57% | 65% | Welsh Carson Anderson & Stowe | Southeast | A |
| Wentworth-Douglass Hospital – Partners HealthCare Acquisition | — | 2,017 | EXPANSION | $200M | 11.1x | — | — | — | — | 38% | Partners HealthCare (now Mass | — | C |
| Acuity Health – Avista Healthcare Partners | — | 2,017 | EXPANSION | $140M | 7.8x | — | — | — | — | 27% | Avista Healthcare Partners | — | C |
| CommuniCare Health Services – Audax Private Equity | — | 2,017 | EXPANSION | $480M | 8.7x | — | — | — | — | 20% | Audax Private Equity | — | C |
| Surgical Care Affiliates – UnitedHealth Group / Optum | — | 2,017 | EXPANSION | $2B | 7.6x | — | — | — | — | — | UnitedHealth Group / Optum | — | C |
| Surgical Care Affiliates (SCA) – UnitedHealth | — | 2,017 | EXPANSION | $2B | 12.1x | — | — | — | — | — | UnitedHealth Group / Optum | — | C |
| Sound Physicians – TPG Growth | — | 2,017 | EXPANSION | $2B | 12.0x | — | — | — | — | — | TPG Growth | — | C |
| PharMerica / KKR Acquisition | — | 2,017 | EXPANSION | $1B | 11.7x | 2.70x | 22.0% | 5.0 | — | 10% | KKR | National | B |
| Privia Health / General Atlantic | — | 2,017 | EXPANSION | $600M | 13.3x | 5.50x | 54.0% | 4.0 | — | 45% | General Atlantic | Mid-Atlantic | B |
| Integrated Oncology Network Add-On | oncology | 2,017 | EXPANSION | $155M | 8.6x | 3.30x | 27.0% | 4.5 | — | 36% | Ridgemont Equity Partners | — | A |
| US Renal Care / Summit Partners LBO | dialysis | 2,017 | EXPANSION | $1B | 10.5x | 3.00x | 24.0% | 5.0 | — | 10% | Summit Partners | — | A |
| Dental Care Alliance / Harvest Partners LBO | dental_dso | 2,017 | EXPANSION | $520M | 11.6x | 3.10x | 27.0% | 4.5 | — | 60% | Harvest Partners | — | A |
| Signify Health / New Mountain Capital LBO + IPO | value_based_care | 2,017 | EXPANSION | $500M | — | 5.50x | 38.0% | 5.0 | — | 8% | New Mountain Capital / public | — | B |
| Surgical Care Affiliates / United Surgical Partners merger | asc | 2,017 | EXPANSION | $2B | 14.0x | 3.80x | 32.0% | 4.0 | — | 62% | Tenet Healthcare / USPI | — | A |
| CONMED Corporation / Gyrus Medical acquisition | asc | 2,017 | EXPANSION | $740M | 16.1x | 2.60x | 20.0% | 4.0 | — | 65% | CONMED Corporation strategic | — | A |
| Quartet Health / Oak HC/FT growth equity | behavioral_health | 2,017 | EXPANSION | $300M | — | 1.20x | 5.0% | 6.0 | — | 55% | Oak HC/FT Partners | — | B |
| Omada Health / Andreessen Horowitz growth equity | digital_health | 2,017 | EXPANSION | $700M | — | 2.50x | 18.0% | 7.0 | — | 60% | Andreessen Horowitz / Cigna Ve | — | B |
| InCompass Health / Elevation Oncology merger | oncology | 2,017 | EXPANSION | $380M | 10.9x | 3.60x | 31.0% | 4.0 | — | 32% | Nautic Partners | — | A |
| Acadia Healthcare Florida/Tennessee BH hospital cluster | behavioral_health | 2,017 | EXPANSION | $680M | 11.0x | 3.00x | 24.0% | 5.0 | — | 38% | Acadia Healthcare (ACHC) | — | A |
| Nexus Health Systems / RehabCare Group add-on | ltach_post_acute | 2,017 | EXPANSION | $220M | 8.5x | 2.40x | 18.0% | 5.0 | — | 13% | ABRY Partners / RehabCare mana | — | A |
| Encompass Health / HealthSouth IRF spin + rebrand | ltach_post_acute | 2,017 | EXPANSION | $6B | 12.0x | 2.50x | 18.0% | 5.0 | — | 16% | HealthSouth Corp (public strat | — | A |
| Ankura Consulting / FTI Health group carve-out | managed_care_services | 2,017 | EXPANSION | $340M | 12.1x | 2.80x | 22.0% | 5.0 | — | — | Bain Capital Special Situation | — | B |
| US Dermatology Partners / BBH (Brockton) roll-up | physician_group | 2,017 | EXPANSION | $190M | 9.5x | 4.00x | 35.0% | 4.0 | — | 62% | BBH Capital Partners | — | A |
| WebMD Health — Internet Brands / KKR Take-Private | health_it | 2,017 | EXPANSION | $3B | 14.0x | 3.50x | 52.0% | 3.0 | — | 10% | Internet Brands / KKR | — | A |
| EyeCare Partners — FFL Partners Buyout | physician_group | 2,017 | EXPANSION | $490M | 10.9x | 3.80x | 60.0% | 3.0 | — | 42% | FFL Partners | — | A |
| Comprehensive Pain Management — Acadia / GTCR Rollup | behavioral_health | 2,017 | EXPANSION | $275M | 9.8x | 3.20x | 34.0% | 4.0 | — | 35% | Acadia Healthcare / GTCR | — | A |
| Castle Biosciences — Dermatology Diagnostics (Growth) | health_it | 2,017 | EXPANSION | $120M | — | 5.00x | 124.0% | 2.0 | — | 33% | Canaan Partners | — | B |
| Azul Senior Care — WCAS SNF Platform | snf | 2,017 | EXPANSION | $480M | 10.7x | 2.50x | 20.0% | 5.0 | — | 12% | Welsh Carson Anderson & Stowe | — | A |
| SCA Health (Surgical Care Affiliates) — Optum | asc | 2,017 | EXPANSION | $2B | 10.5x | 3.80x | 20.0% | 7.0 | — | 48% | UnitedHealth / Optum | — | A |
| IntelliSource Health — Frazier Healthcare Partners | health_it | 2,017 | EXPANSION | $115M | 9.6x | 5.00x | 50.0% | 4.0 | — | 55% | Frazier Healthcare Partners | — | A |
| Community Health Systems Carve-Out – Oak Hill Capital | General Hospitals | 2,017 | EXPANSION | $1B | 13.3x | 1.80x | 11.0% | 5.5 | 68% | 42% | Oak Hill Capital | Southeast | A |
| U.S. Dermatology Partners – ABRY Partners buyout | Dermatology | 2,017 | EXPANSION | $520M | 10.8x | 2.90x | 19.0% | 6.0 | 55% | 79% | ABRY Partners | South | A |
| TeamHealth – Blackstone Buyout | — | 2,016 | CORRECTION | $6B | 13.6x | — | — | — | — | 38% | Blackstone Group | — | C |
| Surgery Partners – Bain Capital / IPO | — | 2,016 | CORRECTION | $1B | 10.0x | — | — | — | — | 55% | Bain Capital (IPO NASDAQ: SGRY | — | C |
| Quorum Health Corporation – CHS Spinoff | — | 2,016 | CORRECTION | $2B | 9.2x | 0.00x | -100.0% | 4.0 | — | 29% | Independent public company (NY | — | B |
| AMSURG + Envision / EmCare Merger | — | 2,016 | CORRECTION | $16B | 14.1x | — | — | 2.0 | — | 37% | Envision Healthcare Holdings ( | — | B |
| Rural Health Group – Cressey Platform | — | 2,016 | CORRECTION | $95M | 7.9x | — | — | — | — | 19% | Cressey & Company | — | C |
| TeamHealth – Blackstone Take-Private | — | 2,016 | CORRECTION | $6B | 12.7x | — | — | — | — | — | Blackstone | — | C |
| AMSURG / Envision Healthcare Merger | — | 2,016 | CORRECTION | $15B | 16.7x | 0.50x | -22.0% | 3.0 | — | 45% | AMSURG (ASC operator) | National | B |
| Hanger Clinic / Welsh Carson Buyout | — | 2,016 | CORRECTION | $1B | 12.6x | 2.10x | 13.0% | 6.0 | — | 30% | Welsh Carson Anderson & Stowe | National | B |
| TeamHealth Physician Staffing Take-Private | physician groups | 2,016 | CORRECTION | $6B | 16.0x | 1.10x | 2.0% | 8.0 | — | 52% | Blackstone | — | A |
| Interim HealthCare / Caring Brands International LBO | home_health | 2,016 | CORRECTION | $210M | 8.4x | 2.40x | 18.0% | 5.0 | — | 25% | Caring Brands (Levine Leichtma | — | A |
| Envision Physician Services / AmSurg / AMSURG merger | physician_group | 2,016 | CORRECTION | $16B | 15.0x | 0.50x | -10.0% | 7.0 | — | 40% | AmSurg + Envision Healthcare | — | A |
| Netsmart Technologies / GI Partners LBO | health_it | 2,016 | CORRECTION | $950M | 16.1x | 3.20x | 28.0% | 4.5 | — | — | GI Partners | — | B |
| Bright Health / New Enterprise Associates growth equity | managed_care | 2,016 | CORRECTION | $500M | — | 0.10x | -32.0% | 6.0 | — | 30% | New Enterprise Associates / mu | — | B |
| Precision Medicine Group / Warburg Pincus growth equity | lab | 2,016 | CORRECTION | $450M | — | 3.80x | 32.0% | 5.0 | — | — | Warburg Pincus | — | C |
| Mednax / NP Pediatrics physician group roll-up | pediatrics | 2,016 | CORRECTION | $2B | 15.0x | 1.50x | 10.0% | 5.0 | — | 52% | Mednax (Physician Partners acq | — | A |
| Crossroads Hospice / LHC Group acquisition | hospice | 2,016 | CORRECTION | $250M | 10.4x | 3.20x | 27.0% | 4.0 | — | 3% | LHC Group | — | A |
| National Western Life / Aon Hewitt benefits carve-out | managed_care | 2,016 | CORRECTION | $280M | 9.0x | 2.10x | 16.0% | 5.0 | — | 82% | Lightyear Capital | — | A |
| TeamHealth / IPC Healthcare merger (pre-KKR) | physician_group | 2,016 | CORRECTION | $6B | 16.0x | 1.10x | 3.0% | 8.0 | — | 40% | Blackstone Group | — | A |
| HAH / Home at Home pediatric nursing (Pediatric Specialty Care) | home_health | 2,016 | CORRECTION | $75M | 7.5x | 4.00x | 35.0% | 4.0 | — | 12% | BelHealth Investment Partners | — | A |
| Mossrehab / Moss Rehab IRF Network expansion | ltach_post_acute | 2,016 | CORRECTION | $320M | 8.9x | 2.10x | 15.0% | 5.0 | — | 17% | Einstein Healthcare Network / | — | A |
| Nant Health / Patrick Soon-Shiong growth equity | health_it | 2,016 | CORRECTION | $3B | — | 0.30x | -20.0% | 7.0 | — | — | Patrick Soon-Shiong / various | — | C |
| Radiology Partners / New Enterprise Associates Series B-D | radiology | 2,016 | CORRECTION | $750M | — | — | — | — | — | 42% | New Enterprise Associates / AD | — | D |
| R1 RCM / TowerBrook + Ascension health system partnership | rcm | 2,016 | CORRECTION | $1B | 20.0x | 5.00x | 40.0% | 5.0 | — | — | TowerBrook Capital Partners + | — | B |
| MEDNAX / Sheridan Anesthesiology merger | anesthesiology | 2,016 | CORRECTION | $2B | 13.0x | 1.40x | 8.0% | 5.0 | — | 49% | MEDNAX Inc (public strategic) | — | A |
| Community Health Systems / Quorum Health distressed spin | hospital | 2,016 | CORRECTION | $1B | 5.5x | 0.30x | -22.0% | 4.0 | — | 26% | CHS management / new equity | — | A |
| Zotec Partners — Court Square Capital Buyout | health_it | 2,016 | CORRECTION | $370M | 8.8x | 3.50x | 28.0% | 5.0 | — | 30% | Court Square Capital Partners | — | A |
| Acute Care / TeamHealth — Blackstone Recap / Secondary | physician_group | 2,016 | CORRECTION | $6B | 12.7x | 1.40x | 5.0% | 7.0 | — | 47% | Blackstone Group | — | A |
| Viad Medical Centers — Warburg Pincus Investment | oncology | 2,016 | CORRECTION | $480M | 10.7x | 3.60x | 29.0% | 5.0 | — | 34% | Warburg Pincus | — | A |
| ExamWorks — Leonard Green & Partners LBO | health_it | 2,016 | CORRECTION | $2B | 12.6x | 2.80x | 22.0% | 5.0 | — | 65% | Leonard Green & Partners | — | A |
| ATI Physical Therapy — Advent International LBO | physical_therapy | 2,016 | CORRECTION | $1B | 12.5x | 0.40x | — | 4.0 | — | 45% | Advent International | — | B |
| InVentiv Health — Thomas H. Lee Buyout | health_it | 2,016 | CORRECTION | $4B | 11.1x | 2.00x | 41.0% | 2.0 | — | 75% | Thomas H. Lee Partners | — | A |
| Cotiviti — Veritas Capital LBO | health_it | 2,016 | CORRECTION | $2B | 10.6x | 3.50x | 52.0% | 3.0 | — | 55% | Veritas Capital | — | A |
| CHA Health Systems — Korean PE Acquisition | hospital | 2,016 | CORRECTION | $1B | 13.3x | 2.50x | 20.0% | 5.0 | — | 30% | MBK Partners (Korean PE) | — | A |
| Netsmart Technologies — GI Partners LBO | health_it | 2,016 | CORRECTION | $960M | 10.1x | 3.20x | 26.0% | 5.0 | — | 25% | GI Partners | — | A |
| Accolade Health — Cigna Investment / IPO | health_it | 2,016 | CORRECTION | $350M | — | 3.00x | 32.0% | 4.0 | — | 88% | Cigna Ventures / Carrick Capit | — | B |
| nThrive RCM / Clearlake Capital | Revenue Cycle Management | 2,016 | CORRECTION | $700M | 8.2x | 2.80x | 23.0% | 5.0 | 62% | 60% | Clearlake Capital Group | National | A |
| Help at Home / Centerbridge Partners | Home Health | 2,016 | CORRECTION | $700M | 10.8x | — | — | — | 55% | 12% | Centerbridge Partners | Midwest | A |
| US Anesthesia Partners – Berkshire Partners | Anesthesiology | 2,016 | CORRECTION | $950M | 11.6x | 2.80x | 22.0% | 5.0 | 65% | 52% | Berkshire Partners / Welsh Car | National | A |
| Premise Health / National Wellness – Investor Group | Employer Health / On-Site Clinics | 2,016 | CORRECTION | $1B | 12.9x | 2.40x | 15.0% | 6.0 | 55% | 88% | OMERS / Warburg Pincus JV | National | A |
| Forefront Dermatology – Wind Point Partners | Dermatology | 2,016 | CORRECTION | $260M | 11.8x | 3.50x | 28.0% | 5.0 | 53% | 80% | Wind Point Partners | Midwest | A |
| IntegraMed Fertility – Lee Equity Partners | Fertility | 2,016 | CORRECTION | $200M | 9.1x | 3.60x | 38.0% | 4.0 | — | 85% | Lee Equity Partners | National | A |
| Surgery Partners – H.I.G. Capital Platform | — | 2,015 | PEAK | $750M | 8.3x | 1.70x | 40.0% | 1.5 | — | 58% | H.I.G. Capital | — | B |
| Kindred Healthcare + Gentiva Health Services Merger | — | 2,015 | PEAK | $2B | 12.9x | — | — | — | — | 17% | Kindred Healthcare | — | C |
| RegionalCare Hospital Partners + Capella Healthcare Merger | — | 2,015 | PEAK | $2B | 11.0x | — | — | 4.0 | — | 30% | RCCH HealthCare Partners (comb | — | B |
| Ardent Health Services – Equity Healthcare / CPPIB Recapitalization | — | 2,015 | PEAK | $2B | 10.6x | — | — | — | — | 31% | Equity Healthcare (Warburg Pin | — | C |
| Select Medical + Concentra Occupational Health Acquisition | — | 2,015 | PEAK | $1B | 10.1x | — | — | — | — | 52% | Select Medical | — | C |
| Kindred Hospital – Kindred Healthcare Integrated Platform | — | 2,015 | PEAK | $900M | 8.2x | — | — | — | — | 18% | Kindred Healthcare | — | C |
| IPC Healthcare – TeamHealth Acquisition | — | 2,015 | PEAK | $2B | 13.3x | — | — | 1.0 | — | 38% | TeamHealth Holdings | — | B |
| Welsh Carson Healthcare Platform – USPI 35% Stake | — | 2,015 | PEAK | $1B | 8.8x | 2.00x | 15.0% | 5.0 | — | 60% | Welsh Carson Anderson & Stowe | — | B |
| AvMed / CareMore Health – Anthem Acquisition | — | 2,015 | PEAK | $800M | 12.3x | 2.50x | 26.0% | 4.0 | — | 13% | Anthem (WellPoint) | — | B |
| RegionalCare + Capella → RCCH HealthCare Partners | — | 2,015 | PEAK | $2B | 9.2x | 2.10x | 22.0% | 3.5 | — | — | CCMP Capital / Warburg Pincus | — | B |
| Surgery Partners / H.I.G. Capital Exit | — | 2,015 | PEAK | $800M | 11.1x | 3.50x | 24.0% | 6.0 | — | 50% | Public (NYSE: SGRY IPO) | National | B |
| Greenway Health / Vista Equity | — | 2,015 | PEAK | $640M | 11.0x | 2.80x | 18.0% | 6.0 | — | — | Vista Equity Partners | Southeast | B |
| Genesis HealthCare / Formation Capital | — | 2,015 | PEAK | $2B | 13.7x | 0.40x | -18.0% | 5.0 | — | 6% | Formation Capital / Fillmore C | Northeast | B |
| Concentra / Humana Acquisition | — | 2,015 | PEAK | $1B | 12.0x | 3.10x | 14.0% | 9.0 | — | 65% | Humana | National | B |
| IPC Healthcare / TeamHealth Acquisition | — | 2,015 | PEAK | $2B | 12.3x | 2.20x | 17.0% | 5.0 | — | 40% | TeamHealth / Blackstone | National | B |
| Behavioral Health Group (BHG) LBO | behavioral health | 2,015 | PEAK | $210M | 10.5x | 4.60x | 35.0% | 5.0 | — | 30% | Frazier Healthcare Partners | — | A |
| Greenway Health RCM / EHR Platform LBO | RCM / health IT | 2,015 | PEAK | $635M | 15.8x | 2.30x | 18.0% | 5.5 | — | — | Vista Equity Partners | — | B |
| Surgery Partners ASC Rollup LBO | ASCs | 2,015 | PEAK | $820M | 11.2x | 4.10x | 36.0% | 4.0 | — | 56% | H.I.G. Capital | — | A |
| Genoptix Oncology Diagnostics Carve-Out | lab diagnostics / oncology | 2,015 | PEAK | $470M | 9.4x | 2.00x | 15.0% | 5.0 | — | 44% | New Mountain Capital | — | A |
| US Acute Care Solutions / Welsh Carson LBO | emergency_medicine | 2,015 | PEAK | $2B | 12.0x | 2.30x | 17.0% | 6.0 | — | 40% | Welsh Carson Anderson & Stowe | — | A |
| InfuSystem / ABRY Partners LBO | infusion | 2,015 | PEAK | $320M | 11.0x | 2.60x | 20.0% | 5.0 | — | 50% | ABRY Partners | — | A |
| Gentiva Health Services / Kindred at Home merger | home_health | 2,015 | PEAK | $2B | 13.0x | 2.50x | 19.0% | 5.0 | — | 12% | Kindred Healthcare / TPG Capit | — | A |
| LabCorp / Covance CRO integration | lab | 2,015 | PEAK | $6B | 14.0x | 2.80x | 20.0% | 5.0 | — | 50% | Laboratory Corporation of Amer | — | A |
| United Behavioral Health / Optum BH carve-out | behavioral_health | 2,015 | PEAK | $5B | 16.0x | 3.10x | 25.0% | 5.0 | — | 45% | Optum / UnitedHealth Group | — | A |
| Ardent Health Services / Equity Group Investments LBO | hospital | 2,015 | PEAK | $2B | 7.5x | 2.20x | 16.0% | 6.0 | — | 30% | Equity Group Investments (Zell | — | A |
| Staywell Health / Carient / Population health JV | population_health | 2,015 | PEAK | $170M | 14.2x | 2.80x | 22.0% | 4.0 | — | 28% | Centene Corporation | — | A |
| Curo Health Services / FC/Patriot Capital add-ons | hospice | 2,015 | PEAK | $320M | 9.4x | 3.40x | 28.0% | 4.5 | — | 4% | Patriot Capital / founding tea | — | A |
| Ardent Health Services — Equity Group Investments Acquisition | hospital | 2,015 | PEAK | $1B | 7.7x | 3.50x | 16.0% | 9.0 | — | 32% | Equity Group Investments (Zell | — | A |
| Surgery Partners — H.I.G. Capital Buyout | asc | 2,015 | PEAK | $760M | 10.6x | 2.20x | 120.0% | 1.0 | — | 44% | H.I.G. Capital / NSH Partners | — | A |
| Concentra — Select Medical / Humana JV | physician_group | 2,015 | PEAK | $1B | 9.2x | 2.50x | 26.0% | 4.0 | — | 45% | Humana / Select Medical | — | A |
| MedExpress Urgent Care — Optum Acquisition | urgent_care | 2,015 | PEAK | $1B | 13.0x | 4.00x | 22.0% | 7.0 | — | 65% | Optum (UnitedHealth) | — | A |
| Radiation Therapy Inc (21st Oncology) — Vistria / WCAS | oncology | 2,015 | PEAK | $580M | 9.7x | 2.80x | 23.0% | 5.0 | — | 29% | Vistria Group / WCAS | — | A |
| Myriad Genetics — Oncology Diagnostics Leader (Benchmark) | health_it | 2,015 | PEAK | $2B | 12.9x | — | — | — | — | 42% | Myriad Genetics (Public, NASDA | — | B |
| InfuCare Rx — Frazier Healthcare Buyout | dme_home_health | 2,015 | PEAK | $145M | 9.7x | 4.80x | 48.0% | 4.0 | — | 46% | Frazier Healthcare Partners | — | A |
| Acadia Healthcare – Warburg Pincus Platform Build | Behavioral Health | 2,015 | PEAK | $580M | 9.4x | 3.10x | 34.0% | 4.2 | 58% | 38% | Warburg Pincus | Southeast | A |
| Surgery Partners – New Mountain Capital LBO | Ambulatory Surgery Centers | 2,015 | PEAK | $760M | 11.2x | 3.80x | 40.0% | 4.0 | 62% | 58% | New Mountain Capital | National | A |
| Community Health Systems – Health Management Associates Acquisition | — | 2,014 | EXPANSION | $8B | 10.1x | — | — | — | — | 32% | Community Health Systems | — | C |
| National Surgical Healthcare – H.I.G. Capital | — | 2,014 | EXPANSION | $475M | 7.7x | 2.80x | 29.0% | 4.0 | — | — | H.I.G. Capital | — | B |
| CareCore National → eviCore Healthcare – Apax Partners | — | 2,014 | EXPANSION | $1B | 7.5x | 2.20x | 26.0% | 3.0 | — | — | Apax Partners | — | B |
| Sheridan Healthcare – AMSURG / Envision | — | 2,014 | EXPANSION | $2B | 9.8x | — | — | — | — | — | AMSURG Corp | — | C |
| Coram / CVS Health Acquisition | — | 2,014 | EXPANSION | $2B | 13.1x | — | — | — | — | 66% | CVS Health / Caremark | National | B |
| Comfort Systems / Rotech Healthcare DME LBO | DME / home respiratory | 2,014 | EXPANSION | $385M | 7.8x | 0.80x | -5.0% | 4.0 | — | 20% | Apax Partners | — | A |
| National Mentor / Centerbridge LBO | home_community_based | 2,014 | EXPANSION | $1B | 9.5x | 2.80x | 22.0% | 5.0 | — | 12% | Centerbridge Partners | — | A |
| PhyAmerica Physician Group / Merit Health take-private | physician_group | 2,014 | EXPANSION | $280M | 9.0x | 2.80x | 22.0% | 5.0 | — | 35% | H.I.G. Capital | — | A |
| IntelliSource / Cotiviti merger (Connecture era) | health_it | 2,014 | EXPANSION | $2B | 18.0x | 4.80x | 36.0% | 5.0 | — | — | Veritas Capital | — | B |
| Carecore National / AIM Specialty Health merger | managed_care_services | 2,014 | EXPANSION | $2B | 20.0x | 5.00x | 40.0% | 4.0 | — | — | Anthem / AIM | — | B |
| Global Indemnity Group / specialty health insurance carve-out | managed_care | 2,014 | EXPANSION | $540M | 10.0x | 2.20x | 17.0% | 5.0 | — | 85% | Warburg Pincus | — | A |
| Physicians Endoscopy / Blue Wolf Capital LBO | asc | 2,014 | EXPANSION | $150M | 8.3x | 3.50x | 30.0% | 4.0 | — | 58% | Blue Wolf Capital Partners | — | A |
| Hanger Prosthetics / Rehabilitation Centers acquisition | dme_home_health | 2,014 | EXPANSION | $2B | 13.0x | 2.10x | 15.0% | 6.0 | — | 33% | Welsh Carson Anderson & Stowe | — | A |
| Emergency Communications Network / TriZetto merger | health_it | 2,014 | EXPANSION | $3B | 20.0x | 4.50x | 38.0% | 4.0 | — | — | Cognizant Technology Solutions | — | B |
| CASI Pharmaceuticals / Chinese market specialty pharma | pharmacy | 2,014 | EXPANSION | $120M | — | 0.70x | -8.0% | 6.0 | — | 75% | Multiple VCs / Frazier Healthc | — | B |
| AmSurg / AMSURG + Envision Premerger physician group | physician_group | 2,014 | EXPANSION | $2B | 14.0x | 2.80x | 22.0% | 4.0 | — | 50% | Sheridan Healthcare / AmSurg | — | A |
| Mednax — Sheridan Healthcare Integration | physician_group | 2,014 | EXPANSION | $2B | 12.6x | — | — | — | — | 42% | MEDNAX Inc (Public) | — | B |
| Ortho Clinical Diagnostics — Carlyle LBO / IPO | health_it | 2,014 | EXPANSION | $4B | 12.2x | 2.00x | 11.0% | 7.0 | — | 65% | Carlyle Group | — | A |
| Premise Health — Warburg Pincus Growth Equity | managed_care | 2,014 | EXPANSION | $350M | 10.0x | 5.50x | 24.0% | 8.0 | — | 85% | Warburg Pincus | — | A |
| Multiplan — Hellman & Friedman LBO | health_it | 2,014 | EXPANSION | $4B | 7.3x | 1.70x | 11.0% | 5.0 | — | 80% | Hellman & Friedman | — | A |
| Enclara Pharmacia — Bankers Life LBO | dme_home_health | 2,014 | EXPANSION | $180M | 8.2x | 3.80x | 31.0% | 5.0 | — | 25% | HarbourVest Partners / Managem | — | A |
| Apria Healthcare / Blackstone → Owens & Minor | Home Health | 2,014 | EXPANSION | $2B | 10.5x | 2.50x | 12.0% | 8.0 | 60% | 30% | Owens & Minor (strategic) | National | A |
| Smile Direct Club – Camelot Venture Group seed | Dental | 2,014 | EXPANSION | $45M | — | 8.50x | 55.0% | 5.0 | — | 20% | Camelot Venture Group | National | B |
| Tenet Healthcare – Vanguard Health Systems Acquisition | — | 2,013 | EXPANSION | $4B | 10.2x | — | — | — | — | 37% | Tenet Healthcare | — | C |
| National Surgical Healthcare – H.I.G. Capital | — | 2,013 | EXPANSION | $450M | 8.2x | 2.90x | 41.0% | 3.0 | — | 62% | H.I.G. Capital | — | B |
| RadNet Radiology Take-Private | radiology | 2,013 | EXPANSION | $760M | 10.2x | 0.70x | -8.0% | 3.0 | — | 50% | Leonard Green & Partners | — | A |
| National Imaging Associates / Magellan Health carve-out | radiology_imaging | 2,013 | EXPANSION | $620M | 11.9x | 2.20x | 17.0% | 6.0 | — | 65% | Magellan Health | — | A |
| Veracyte — TPG Investment / IPO | health_it | 2,013 | EXPANSION | $300M | — | 4.50x | 66.0% | 3.0 | — | 28% | TPG Biotech / Public | — | B |
| Vibra Healthcare – Sterling Capital Recap | — | 2,012 | EXPANSION | $420M | 8.1x | — | — | — | — | 24% | Sterling Capital Partners | — | C |
| HealthSpring – Cigna Acquisition | — | 2,012 | EXPANSION | $4B | 12.3x | — | — | — | — | 11% | Cigna Corporation | — | C |
| DaVita HealthCare Partners – DaVita Acquisition | — | 2,012 | EXPANSION | $4B | 12.6x | — | — | — | — | 30% | DaVita Inc | — | C |
| Apria Healthcare / Blackstone take-private + re-IPO | dme_home_health | 2,012 | EXPANSION | $1B | 6.5x | 3.30x | 28.0% | 4.0 | — | 30% | Blackstone Group | — | A |
| Aspen Dental — Leonard Green & Partners Recap | dental | 2,012 | EXPANSION | $900M | 12.9x | 4.20x | 27.0% | 6.0 | — | 55% | Leonard Green & Partners | — | A |
| Radiology Partners – New Enterprise Associates platform | Radiology | 2,012 | EXPANSION | $120M | 8.0x | 5.20x | 21.0% | 8.0 | — | 55% | New Enterprise Associates | National | A |
| Acadia Healthcare – Waud Capital IPO Platform | — | 2,011 | RECOVERY | $300M | 7.1x | 4.20x | 61.0% | 3.0 | — | 33% | Waud Capital Partners (pre-IPO | — | B |
| EmCare Holdings – Leonard Green & Partners | — | 2,011 | RECOVERY | $1B | 10.0x | 3.50x | 29.0% | 5.0 | — | 40% | Leonard Green & Partners | — | B |
| Acadia Healthcare – Waud Capital Build-up | — | 2,011 | RECOVERY | $120M | 6.7x | 12.50x | 40.0% | 7.0 | — | — | Waud Capital Partners | — | B |
| US Renal Care Dialysis LBO | dialysis | 2,011 | RECOVERY | $540M | 9.8x | 3.10x | 24.0% | 5.5 | — | 18% | Summit Partners | — | A |
| Acadia Healthcare Behavioral Health IPO | behavioral health | 2,011 | RECOVERY | $950M | 14.0x | 8.20x | 58.0% | 4.0 | — | 42% | Waud Capital Partners | — | B |
| AccordantHealth / Humana spinout (Evolent Health predecessor) | population_health | 2,011 | RECOVERY | $200M | — | 6.00x | 42.0% | 5.0 | — | 30% | TPG Capital / UPMC | — | B |
| Acadia Healthcare / Waud Capital LBO | behavioral_health | 2,011 | RECOVERY | $620M | 9.5x | 8.20x | 58.0% | 4.0 | — | 42% | Waud Capital Partners | — | B |
| MedQuist / Nuance Communications health IT acquisition | health_it | 2,011 | RECOVERY | $360M | 10.9x | 2.50x | 18.0% | 5.0 | — | — | Nuance Communications / Micros | — | B |
| CareMore Health / Anthem acquisition | managed_care | 2,011 | RECOVERY | $800M | — | 4.00x | 28.0% | 6.0 | — | 0% | Anthem / WellPoint | — | B |
| CareMore Health — Anthem Strategic Acquisition | managed_care | 2,011 | RECOVERY | $800M | 14.5x | 3.50x | 28.0% | 5.0 | — | 8% | Anthem (WellPoint) | — | A |
| Emergency Medical Services (EMSC) — Onex Take-Private | physician_group | 2,011 | RECOVERY | $3B | 12.3x | 3.10x | 33.0% | 4.0 | — | 48% | Onex Corporation | — | A |
| Healogics — Waud Capital Buyout | physician_group | 2,011 | RECOVERY | $310M | 8.2x | 3.80x | 30.0% | 5.0 | — | 22% | Waud Capital Partners | — | A |
| Genoptix Medical Laboratory — Novartis Acquisition | health_it | 2,011 | RECOVERY | $470M | 9.4x | — | — | — | — | 32% | Novartis AG | — | B |
| Psychiatric Solutions – Universal Health Services Acquisition | — | 2,010 | RECOVERY | $3B | 11.1x | — | — | — | — | 30% | Universal Health Services | — | C |
| Steward Health Care – Cerberus Capital Acquisition | — | 2,010 | RECOVERY | $895M | 19.9x | 0.00x | -15.0% | 14.0 | — | 26% | Cerberus Capital Management | — | B |
| Prospect Medical Holdings – Leonard Green & Partners | — | 2,010 | RECOVERY | $363M | 9.1x | 0.30x | -8.0% | 14.0 | — | 28% | Leonard Green & Partners | — | B |
| Essent Healthcare – CHS Acquisition | — | 2,010 | RECOVERY | $134M | 7.4x | — | — | — | — | 31% | Community Health Systems | — | C |
| RegionalCare Hospital Partners – Foundation / Management Recap | — | 2,010 | RECOVERY | $650M | 9.0x | 2.60x | 21.0% | 5.0 | — | 29% | Foundation Capital / managemen | — | B |
| US Oncology / McKesson Acquisition | — | 2,010 | RECOVERY | $2B | 12.0x | 3.20x | 20.0% | 7.0 | — | 42% | McKesson Corporation | National | B |
| Steward Health Care / Cerberus Capital LBO | hospital | 2,010 | RECOVERY | $895M | 7.5x | 0.40x | -6.0% | 14.0 | — | 20% | Cerberus Capital Management | — | A |
| Prospect Medical Holdings / Leonard Green take-private | hospital | 2,010 | RECOVERY | $363M | 6.5x | 0.80x | -3.0% | 13.0 | — | 22% | Leonard Green & Partners | — | A |
| US Oncology — McKesson Strategic Acquisition | oncology | 2,010 | RECOVERY | $2B | 11.7x | 3.20x | 26.0% | 5.0 | — | 35% | McKesson Corporation | — | A |
| TeamHealth – Blackstone 1st LBO | — | 2,009 | CONTRACTION | $1B | 7.5x | 2.60x | 24.0% | 4.5 | — | — | Blackstone | — | B |
| Surgical Care Affiliates (SCA) / Frist & KKR LBO | asc | 2,007 | PEAK | $1B | 10.0x | 3.80x | 30.0% | 5.0 | — | 64% | KKR / Frist family | — | A |
| Pacific Dental Services — NMS Capital Take-Private | dental | 2,007 | PEAK | $340M | 8.9x | 4.50x | 21.0% | 8.0 | — | 60% | NMS Capital | — | A |
| HCA Healthcare – KKR / Bain Capital LBO | — | 2,006 | EXPANSION | $33B | 13.8x | 2.40x | 19.0% | 5.0 | — | 40% | KKR / Bain Capital / Merrill L | — | B |
| Capella Healthcare – Martin Ventures Buyout | — | 2,006 | EXPANSION | $800M | 9.4x | 2.10x | 9.0% | 9.0 | — | 30% | Martin Ventures / SunTrust Cap | — | B |
| MinuteClinic / CVS Health | — | 2,006 | EXPANSION | $170M | — | — | — | — | — | 70% | CVS Health | National | D |
| Select Medical – Warburg Pincus LBO | — | 2,005 | EXPANSION | $2B | 9.3x | 2.30x | 23.0% | 4.0 | — | 27% | Warburg Pincus | — | B |
| Select Medical / Welsh Carson | — | 2,005 | EXPANSION | $2B | 12.0x | 4.20x | 17.0% | 10.0 | — | 35% | Welsh Carson Anderson & Stowe | National | B |
| Select Medical – Welsh Carson recapitalization | Post-Acute | 2,005 | EXPANSION | $2B | 7.5x | 2.80x | 12.0% | 9.0 | 70% | 20% | Welsh Carson Anderson & Stowe | National | A |
| Vanguard Health Systems – Blackstone Buyout | — | 2,004 | EXPANSION | $1B | 9.5x | 3.10x | 13.0% | 9.0 | — | 38% | Blackstone Group | — | B |
| IASIS Healthcare – TPG Capital Buyout | — | 2,004 | EXPANSION | $1B | 9.4x | 2.10x | 6.0% | 13.0 | — | 30% | TPG Capital | — | B |
| Vitas Healthcare / Chemed Corporation acquisition | hospice | 2,004 | EXPANSION | $410M | 12.1x | 5.80x | 16.0% | 12.0 | — | 5% | Chemed Corporation (strategic) | — | A |
| IASIS Healthcare / TPG Capital LBO | hospital | 2,004 | EXPANSION | $1B | 7.5x | 2.50x | 18.0% | 7.0 | — | 28% | TPG Capital | — | A |
| Healtheon / WebMD Health merger (original digital health) | health_it | 1,999 | UNKNOWN | $8B | — | 0.50x | -8.0% | 8.0 | — | — | WebMD Health / Emdeon Communic | — | C |